{
  "meta": {
    "title": "272_Obstetrics_And_Gynecology_Aiims_2018",
    "url": "https://brainandscalpel.vercel.app/272-obstetrics-and-gynecology-aiims-2018-b0a9270c.html",
    "scrapedAt": "2025-11-30T12:57:39.938Z"
  },
  "questions": [
    {
      "text": "Identify the instrument.",
      "choices": [
        {
          "id": 1,
          "text": "Episiotomy scissors"
        },
        {
          "id": 2,
          "text": "Curved artery"
        },
        {
          "id": 3,
          "text": "Curve-bladed Mayo"
        },
        {
          "id": 4,
          "text": "Mosquito forceps"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given instrument is <strong>Episiotomy scissors</strong>.</p>\n<p>The episiotommy scissors is <strong>angulated</strong> to <strong>prevent extensions</strong> of the perineal&nbsp;<strong>tears</strong> into the anal margins and anal spinchters and it also prevents complete perineal tears.</p>\n<p>Episiotomy is a&nbsp;<strong>planned</strong> <strong>incision</strong>&nbsp;made on the <strong>posterior vaginal wall</strong> and the <strong>perineum</strong> during the <strong>second stage of labor</strong>. It is done mostly to avoid spontaneous perineal injuries to the muscles and fascia at the time of delivery.</p>\n<p>The <strong>ideal time</strong> to perform episiotomy is when the <strong>perineum</strong> is <strong>bulged thin</strong> during contraction, <strong>just prior to crowning</strong>. The most commonly performed episiotomy incision is <strong>mediolateral</strong>, which <strong>prevents</strong> any <strong>rectal involvement</strong> even if the tear extends posteriorly. Other types of episiotomy include: Median,lateral and J shaped.</p>\n<p><strong>Curved Mayo</strong> (option C)&nbsp; is used to <strong>cut thicker tissues</strong>.</p>\n<p><strong>Mosquito forceps</strong> (option D)&nbsp; is used to <strong>grasp</strong> the <strong>delicate tissues &amp; blood vessels</strong>.</p>\n<p>The table below explains major differences between median and mediolateral type of episiotomy.</p><table>\n<tbody>\n<tr>\n<td><strong>Midline Episiotomy</strong></td>\n<td><strong>Mediolateral Episiotomy</strong></td>\n</tr>\n<tr>\n<td>Surgical repair is easy</td>\n<td>Surgical repair is difficult</td>\n</tr>\n<tr>\n<td>Blood loss is lesser</td>\n<td>Blood loss is more</td>\n</tr>\n<tr>\n<td>Healing is superior</td>\n<td>Healing is not so good</td>\n</tr>\n<tr>\n<td>Dyspareunia is rare</td>\n<td>Dyspareunia is comparatively more</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Postoperative comfort is maximum</p>\n</td>\n<td>\n<p class=\"p1\">Postoperative discomfort is more</p>\n</td>\n</tr>\n<tr>\n<td>\n<p class=\"p1\">Extension, if occurs, may involve the rectum</p>\n</td>\n<td>\n<p class=\"p1\">Relative safety from <strong>rectal involvement</strong> from extension&nbsp;</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Instruments in OBG</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59138be1e8d141fe9ebaef4f7e659432x1181x870.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/733db2f903e2492a86c5426c9474709bx1280x938.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1d44522851ed42ec8da170d61c415f12x1159x933.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8cbd2117a78e4c31a4487cddaa43a2c2x871x617.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6d38c784ac734fa3ace7fd390520778ax880x699.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/47aee7f73b87421a9faa3402828666bfx953x721.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/072c8ca058fd4f4d92e6ae299cfdbd04x735x592.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/05dc8444e062403f8c826a7ad52c00d9x759x574.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f40b790592224b05ac1d680696b5c5bcx806x609.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2af70bdfbb4f4253992b9813d001f51dx800x600.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/42a06419caad4e8bb379998dfc73f30cx953x691.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1260a318cf0049718c5175a47f084400x855x654.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/46a8dbc68e894ba8b91d4c14d19b515ex771x677.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4b753a73ddde4ea2acc7c461fb7292a8x762x739.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/26a35cac6bd747bf957fed883a1fd850x922x638.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/91c0754e8b4846c0a6325cbf2e4f8721x1203x701.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/12052a1ae2a64be6937c40bbc4009652x750x705.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Mediolateral Episiotomy</h3><p>It begins within 3 mm of the midline in the posterior fourchette and is directed laterally at an angle of at least <strong>60 degrees</strong> from the midline. This yields an incision of&nbsp;<strong>45</strong>&nbsp;<strong>degrees</strong> off the midline.</p>\n<p>It is essentially an inflicted second-degree perineal tear.</p>\n<p><strong>Structures cut in mediolateral episiotomy:</strong></p>\n<ul>\n<li>Posterior vaginal wall</li>\n<li>Superficial and deep transverse perineal muscles, bulbospongiosus and part of levator ani</li>\n<li>Fascia covering those muscles</li>\n<li>Transverse perineal branches of pudendal vessels and nerves</li>\n<li>Subcutaneous tissue and skin</li>\n</ul>\n<p><strong>Advantage:</strong> Lesser risk of&nbsp;anal sphincter laceration, hence&nbsp;it is<strong>&nbsp;preferred </strong>over median episiotomy.</p>\n<p><strong>Disadvantage:</strong> Increased blood loss and causes more perineal pain and dyspareunia.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3b63de15769847739008d216f6d7b34cx1280x1669.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4850ee6ba8fa48a3a28d03b004ec8ad8.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3499",
      "difficulty": "easy"
    },
    {
      "text": "At term pregnancy, the normal amniotic fluid appearance is __________.",
      "choices": [
        {
          "id": 1,
          "text": "Clear with white specks"
        },
        {
          "id": 2,
          "text": "Cloudy without white specks"
        },
        {
          "id": 3,
          "text": "Clear without white specks"
        },
        {
          "id": 4,
          "text": "Cloudy with white specks"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>At <strong>term</strong>, the <strong>amniotic fluid</strong> is <strong>cloudy</strong> and contains a <strong>large number of white flakes</strong> of vernix.</p>\n<p>Amniotic fluid <strong>appearance</strong> is determined by the <strong>proportion of</strong> <strong>cloudiness</strong> and the <strong>number of flakes</strong> <strong>released</strong> from the fetal skin <strong>over the period of pregnancy</strong>. This is summated by the <strong>amniotic fluid macroscore</strong>.</p>\n<p>At the end of the<strong> 32 nd week</strong> of pregnancy, the amniotic fluid is <strong>clear</strong> and does <strong>not have any flakes</strong> (Option C). By the <strong>36 th</strong> <strong>week</strong>, the amniotic fluid starts to have <strong>some flakes</strong> (Option A) and gradually we will begin to see traces of cloudiness also. By <strong>42 nd week</strong>.i.e. <strong>term</strong> of pregnancy, the amniotic fluid has a <strong>large number of flakes and is very cloudy</strong> (Option D).</p><hr><h3>Related Pearl: Indications of Amniotic Fluid Color</h3><table>\n<tbody>\n<tr>\n<td><strong>Amniotic fluid colour </strong></td>\n<td><strong>Inference</strong></td>\n</tr>\n<tr>\n<td>Colourless</td>\n<td>Early pregnancy</td>\n</tr>\n<tr>\n<td>Straw yellow&nbsp;</td>\n<td>Term pregnancy (exfoliated lanugo, epidermal cells from fetal skin)</td>\n</tr>\n<tr>\n<td>Meconium stained (green)</td>\n<td>Fetal distress (other than breech / transverse)</td>\n</tr>\n<tr>\n<td>Golden&nbsp;</td>\n<td>Rh incompatibility (excessive hemolysis of fetal RBC, excess bilirubin)</td>\n</tr>\n<tr>\n<td>Greenish yellow (saffron)</td>\n<td>Post maturity</td>\n</tr>\n<tr>\n<td>Dark red</td>\n<td>Concealed accidental hemorrhage (contamination of blood)</td>\n</tr>\n<tr>\n<td>Dark brown (tobacco juice)</td>\n<td>Intrauterine death (presence of old HbA)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Change in the amniotic fluid volume through gestation</h3><table>\n<tbody>\n<tr>\n<td><strong>Period of gestation </strong> &nbsp;</td>\n<td><strong>Amniotic fluid volume </strong></td>\n</tr>\n<tr>\n<td>10 weeks</td>\n<td>10-20 mL</td>\n</tr>\n<tr>\n<td>16 weeks</td>\n<td>250 mL</td>\n</tr>\n<tr>\n<td>33 weeks</td>\n<td>800 mL</td>\n</tr>\n<tr>\n<td>38-39 weeks</td>\n<td>plateaus at 1000 mL</td>\n</tr>\n<tr>\n<td>40 weeks</td>\n<td>&nbsp;800</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: The average volume increases with gestational age, peaking at <strong>800-1000 mL</strong>, which coincides with <strong>36-37</strong> weeks' gestation.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC3503",
      "difficulty": "hard"
    },
    {
      "text": "Identify this condition.",
      "choices": [
        {
          "id": 1,
          "text": "Twin to Twin Transfusion Syndrome"
        },
        {
          "id": 2,
          "text": "Monochorionic diamniotic pregnancy"
        },
        {
          "id": 3,
          "text": "Monochorionic monoamniotic pregnancy"
        },
        {
          "id": 4,
          "text": "Dichorionic diamniotic pregnancy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given specimen depicts a <strong>monochorionic</strong> <strong>monoamniotic</strong> pregnancy as:</p>\n<ul>\n<li aria-level=\"1\"><strong>2 umbilical cords</strong> are arising from <strong>1 placenta </strong>(<strong>monochorionic</strong>)</li>\n<li aria-level=\"1\"><strong>No intervening amniotic membrane</strong> is attached to the placenta. This means that both fetuses must have been inside a single amniotic cavity (<strong>monoamniotic</strong>).&nbsp;</li>\n</ul>\n<p>Option B: In <strong>Monochorionic diamniotic</strong> pregnancy, on <strong>gross examination</strong>, there will be <strong>1 placenta</strong> and <strong>intervening</strong> 2 layers of <strong>amnion attached</strong> to the placenta. In this type of pregnancy, each fetus will have its own amniotic cavity (diamniotic) with a shared placenta (monochorionic). This is seen if the <strong>fertilized zygote divides&nbsp;</strong>into 2&nbsp;between <strong>4-8 days</strong>.</p>\n<p>The below given gross image of <strong>monochorionic diamniotic pregnancy</strong> shows <strong>two umbilical cords</strong> arising separately from the placenta with the <strong>intervening amniotic membrane</strong> held by the forceps.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6faf0d666866408e88d09d1ca99e6b1fx382x566.PNG\" alt=\"Explanation Image\"><p>Option D: In <strong>dichorionic diamniotic</strong> pregnancy each fetus has it&rsquo;s own <strong>amnion &amp; chorion</strong>. The placentas here may be fused or separate. This is seen in <strong>dizygotic twins</strong> as well as <strong>monozygotic twins that divide</strong> within <strong>0-4 days</strong>.</p>\n<p>Option A: <strong>Twin to twin transfusion syndrome</strong> (TTTS)&nbsp; most commonly complicates <strong>monochorionic</strong> (single placenta) <strong>twin pregnancy</strong>. In TTTS blood is transfused from the donor twin to the recipient twin through the abnormal vascular connections within the placenta leaving the donor anemic while the recipient becomes polycythemic.</p><p>The box below describes the type of amnion and chorion seen in different types of twins depending on the time of division.</p>\n<table>\n<tbody>\n<tr>\n<td>Dizygotic twins</td>\n<td>Dichorionic diamniotic</td>\n</tr>\n<tr>\n<td>\n<p>Monozygotic twins- division occurs within</p>\n<p>0-4 days</p>\n<p>4-8 days</p>\n<p>8-12 days</p>\n<p>&gt;13 days</p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>Dichorionic diamniotic</p>\n<p>Monochorionic diamniotic</p>\n<p>Monochorionic monoamniotic</p>\n<p>Monochorionic monoamniotic conjoined twins</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br /><br /></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1828892d8b264029afc5e0f9fdde741ex1280x5795.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/299f93b512f2498693c743c9fa249349.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5266",
      "difficulty": "medium"
    },
    {
      "text": "A lady with 7 weeks amenorrhea presented with slight vaginal spotting. Crown Rump Length was 5 mm with a well-formed gestational sac with a calculated gestational age of 5.6 weeks on TVS. What is the next line of management?",
      "choices": [
        {
          "id": 1,
          "text": "Wait and watch for 4 weeks"
        },
        {
          "id": 2,
          "text": "Repeat TVS after one week"
        },
        {
          "id": 3,
          "text": "Serum HCG levels"
        },
        {
          "id": 4,
          "text": "Medical intervention"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"page\" title=\"Page 374\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<div class=\"page\" title=\"Page 374\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The given clinical scenario of a patient with <strong>amenorrhea</strong> presenting <strong>with spotting</strong>, raises a <strong>suspicion of</strong> possible <strong>abortion</strong> and in the given case the <strong>next line of management</strong> would be to <strong>repeat TVS after one week</strong>.</p>\n<p>In a normal <strong>intrauterine pregnancy</strong> a <strong>gestational sac</strong> will be visible on TVS by<strong> 5 weeks</strong> of LMP and the <strong>embryonic poles</strong> can be visualized by <strong>5.5 weeks</strong>. The <strong>cardiac activity</strong> of the embryo can be first visualized <strong>on TVS</strong> around <strong>5.5-6 weeks, </strong>when the <strong>crown rump length</strong> (<strong>CRL</strong>)<strong> </strong>is around<strong> 5mm</strong>.</p>\n<p>In the event that, the <strong>embryonic poles</strong> are <strong>not visible</strong> on TVS, even when the <strong>gestational sac diameter</strong> has reached <strong>≥25mm</strong> or the <strong>cardiac activity</strong> is <strong>not visualized</strong> even at<strong> CRL ≥7mm</strong> a <strong>diagnosis</strong> of <strong>missed abortion</strong> can be made. The values, <strong>mean sac</strong> (gestational sac) diameter ≥25mm and CRL ≥7mm are known as <strong>critical cut off values</strong> which represent the <strong>upper limit</strong> beyond which if a structure is not visualized, it is abnormal.</p>\n<p>Hence, <strong>Missed Abortion</strong> should be suspected if, on USG </p>\n<ul>\n<li aria-level=\"1\"><strong>CRL ≥7 mm and no heart beat is recorded</strong> (CRL-crown rump length)</li>\n<li aria-level=\"1\"><strong>MSD ≥25 mm and no embryo is seen</strong> (MSD-mean sac diameter)</li>\n</ul>\n<p>In this patient the <strong>CRL is still at 5 mm </strong>and hence, a diagnosis of missed abortion cannot be made. Thus, the <strong>next line of management</strong> would be to <strong>repeat TVS after one week</strong>.</p>\n<table>\n<tbody>\n<tr>\n<th>Structure</th>\n<th>Critical cut-off to visualize the structure on USG</th>\n<th>Structure visible on TVS at</th>\n</tr>\n</tbody>\n<tbody>\n<tr>\n<td>Gestational sac in uterus(intrauterine pregnancy)</td>\n<td>On TVS : 2000 IU of beta HCG<br />On TAS :6500 IU of beta HCG</td>\n<td>4 weeks 3 days of LMP to 5 weeks</td>\n</tr>\n<tr>\n<td>Yolk sac</td>\n<td>-</td>\n<td>5 weeks</td>\n</tr>\n<tr>\n<td>embryonic/fetal poles</td>\n<td>Mean sac diameter &gt;/= 25 mm</td>\n<td>5 weeks - 5 1/2 weeks</td>\n</tr>\n<tr>\n<td>Cardiac activity</td>\n<td>CRL &gt;/= 7mm</td>\n<td>5 1/2 weeks - 6 weeks</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5986",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following would be considered as an absolute contraindication for insertion of copper T to a patient?",
      "choices": [
        {
          "id": 1,
          "text": "Unmotivated patient"
        },
        {
          "id": 2,
          "text": "Menorrhagia"
        },
        {
          "id": 3,
          "text": "Previous ectopic pregnancy"
        },
        {
          "id": 4,
          "text": "Previous history of abortion"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>An <strong>unmotivated patient</strong> or someone who does not consent to the procedure should never be taken up for a procedure.</p>\n<p><strong>Contraindications for use of copper intrauterine devices (IUDs)</strong></p>\n<ul>\n<li>Uterine abnormality with a distorted uterine cavity</li>\n<li><strong>Active</strong> uterine and pelvic <strong>infection</strong></li>\n<li>Known or suspected uterine or cervical malignancy</li>\n<li>Genital bleeding of unknown etiology</li>\n<li>Mucopurulent cervicitis</li>\n<li>Wilson disease</li>\n<li>A previously placed IUD that has not been removed</li>\n<li>An inability to place or retain the device</li>\n</ul>\n<p><strong>Note</strong>:&nbsp;</p>\n<p>An unmotivated patient is an absolute contraindication. Out of the given options, this would be the best answer.&nbsp;&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5268",
      "difficulty": "medium"
    },
    {
      "text": "A 76 year-old female presented with a non-healing ulcer on the labia majora for a period of 6 months, measuring 2 cm x 3 cm. No lymph nodes were palpable. Biopsy shows squamous cell carcinoma. How do you manage this case?",
      "choices": [
        {
          "id": 1,
          "text": "Total vulvectomy with unilateral LN dissection"
        },
        {
          "id": 2,
          "text": "Partial vulvectomy with ipsilateral inguinofemoral  LN dissection"
        },
        {
          "id": 3,
          "text": "Simple vulvectomy"
        },
        {
          "id": 4,
          "text": "Chemoradiation with resection"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>According to the recent <strong>FIGO guidelines</strong>,the patient&rsquo;s lesion measuring <strong>2 cm x 3 cm</strong> with <strong>no palpable lymph nodes</strong> falls under <strong>stage Ib </strong>vulval cancer<strong>&nbsp;</strong>and it's management is<strong>&nbsp;partial vulvectomy </strong>with<strong> ipsilateral inguinofemoral lymph node dissection.</strong></p>\n<p>For <strong>stage IB</strong> cancers, <strong>radical partial vulvectomy</strong> is recommended for the <strong>primary tumor </strong>and&nbsp;as the women with stage IB cancer can have <strong>diseased lymph nodes</strong> even <strong>without palpable enlargement</strong> of nodes, <strong>Sentinel Lymph Node Biopsy</strong> (SLNB) and/ <strong>inguinofemoral lymphadenectomy</strong> is performed.</p>\n<p><strong>Ipsilateral dissection</strong> of lymph nodes is performed if the <strong>vulvar lesion</strong> is present <strong>laterally</strong>, &gt;2cm beyond the midline. In cases where the vulvar <strong>lesion</strong> lies <strong>within 2 cm</strong> from the<strong> midline</strong>, <strong>bilateral inguinofemoral</strong> Lymph Node dissection will be performed.</p>\n<p>In this patient, the best management would be to perform Partial vulvectomy with ipsilateral inguinofemoral LN dissection among the given options.</p><hr><h3>Related Pearl: Staging of Vulval Cancer (FIGO)</h3><table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Features</strong></td>\n</tr>\n<tr>\n<td><strong>I</strong></td>\n<td>Tumor confined to vulva</td>\n</tr>\n<tr>\n<td>IA</td>\n<td>Lesions&nbsp;&le;2 cm in size, confined to the vulva or perineum and with stromal invasion&nbsp;&le; 1 mm, no nodal metastasis</td>\n</tr>\n<tr>\n<td>IB</td>\n<td>Lesions &gt;2cm in size or with stromal invasion &gt;1mm , confined to the vulva or perineum, with negative nodes</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>Tumor of any size with extension to adjacent perineal structures (lower 1/3<sup>rd</sup> urethra, lower 1/3<sup>rd</sup> vagina, anus) with negative nodes</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>Tumor of any size with/without extension to adjacent perineal structures (lower 1/3<sup>rd</sup> urethra, lower 1/3<sup>rd</sup> vagina, anus) with positive inguinofemoral lymph nodes</td>\n</tr>\n<tr>\n<td>IIIA</td>\n<td>i) With 1 lymph node macrometastases (&ge;5mm) or,</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>ii)1-2 lymph node micrometastases(&lt;5mm)</td>\n</tr>\n<tr>\n<td>IIIB</td>\n<td>i) With 2 or more lymph node macrometastases (&ge;5mm), or</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>ii) 3 or more lymph node micrometastases (&lt;5 mm)</td>\n</tr>\n<tr>\n<td>IIIC</td>\n<td>With positive nodes with extracapsular spread</td>\n</tr>\n<tr>\n<td><strong>IV</strong></td>\n<td>Tumor invades other regional structures (upper 2/3<sup>rd</sup> urethra, upper 2/3<sup>rd</sup> vagina) or distant structures</td>\n</tr>\n<tr>\n<td>IVA</td>\n<td>Tumour invades any of the following:</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>i) Upper urethral and/or vaginal mucosa, bladder mucosa, rectal mucosa, or fixed to the pelvic bone, or</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>ii) Fixed or ulcerated inguinofemoral lymph nodes</td>\n</tr>\n<tr>\n<td>IVB</td>\n<td>Any distant metastasis including pelvic lymph nodes</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Treatment Modality in Vulval Cancer</h3><table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Treatment </strong></td>\n</tr>\n<tr>\n<td><strong>1A</strong></td>\n<td>\n<ul>\n<li>&nbsp;Radical wide local excision\n<div class=\"layoutArea\">&nbsp;</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>1B</strong></td>\n<td>\n<ul>\n<li>Partial vulvectomy + ipsilateral inguinofemoral lymph node dissection</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>\n<ul>\n<li>Tumor 2-4cm &ndash; total vulvectomy + B/L groin lymph node dissection</li>\n<li>Tumor &gt;4cm or poorly differentiated &ndash; radical vulvectomy + B/L lymphadenectomy + pelvic lymph node dissection</li>\n</ul>\n<div class=\"page\" title=\"Page 493\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>\n<ul>\n<li>Megavoltage radiotherapy</li>\n<li>Local surgical excision -&nbsp;Radical vulvectomy + B/L lymphadenectomy + pelvic lymph node dissection</li>\n<li>Local recurrence &ndash; chemotherapy</li>\n</ul>\n<div class=\"page\" title=\"Page 493\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td><strong>IV</strong></td>\n<td>\n<ul>\n<li>Chemotherapy or radiotherapy</li>\n<li>Local excision on residual tumor</li>\n<li>ipsilateral inguinofemoral lymph node + ve &ndash; contralateral node removed</li>\n<li>Femoral lymph node +ve &ndash; pelvic lymph node removed</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5267",
      "difficulty": "medium"
    },
    {
      "text": "A female comes to Gynecology OPD for pre-conceptual counseling, with 2 prior second trimester abortions. What is the next investigation you will advise?",
      "choices": [
        {
          "id": 1,
          "text": "Pelvic sonography"
        },
        {
          "id": 2,
          "text": "Hysterosalpingography"
        },
        {
          "id": 3,
          "text": "Endometrial Biopsy"
        },
        {
          "id": 4,
          "text": "Karyotyping of the parents"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The most common cause of <strong>second trimester abortions</strong> are <strong>uterocervical structural anomalies</strong> and the<strong> next investigaton</strong> advised in this patient would be <strong>pelvic sonography </strong>to look for these anomalies.</p>\n<p>Although, <strong>Hysterosalpingography</strong> (Option B) can be used in the patient during the <strong>interconceptional period</strong> to diagnose internal anatomical abnormalities of the uterus and cervix, it is an <strong>invasive procedure</strong> and hence is reserved for use only after nonivasive procedures such as sonography is done. Hysterosalpingography (HSG) has limited use in diagnosing the external uterine contour and it is <strong>contraindicated in pregnancy</strong>.</p>\n<p><strong>Pelvic sonography</strong> is a <strong>non-invasive</strong> investigation that can be used to detect certain <strong>anatomical anomalies</strong> leading to abortions. A 3D sonography will provide better images of uterine and cervical contour than a 2D sonography. This investigation <strong>can</strong> also <strong>be done</strong> in <strong>pregnant female</strong>.</p>\n<p><strong>Karyotyping</strong> (Option D) is done to rule out any suspicion of <strong>chromosomal abnormalities</strong> which, more commonly cause <strong>first trimester abortions.</strong></p>\n<div class=\"page\" title=\"Page 220\">\n<table>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Some Causes of Midtrimester(second trimester) abortions</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Fetal Anomalies- Structural,Chromosomal</p>\n<p>Maternal Disorders-Autoimmune, Infections, Metabolic disorders</p>\n</div>\n<div class=\"column\">\n<p>Placental Causes-Abruption, previa Vasculopathy,Chorioamnionitis</p>\n<p>Uterine Defects-Congenital anomalies, submucosal Leiomyomas, cervical incompetance</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>NOTE: If a suspicion of <strong>cervical incompetence</strong> (H/O <strong>1</strong> painless<strong> second trimester loss</strong>) is present, a <strong>TVS</strong> is performed in a <strong>pregnant female</strong> between <strong>18-24weeks</strong> and the <strong>cervical length </strong>and the <strong>cervical shape</strong> is determined.</p>\n<ul>\n<li>Normal cervical length-3-4cm ; In cervical incompetence ≤2.5cm</li>\n<li>Normal cervix shape-Tshape; In cervical incompetence U shape</li>\n</ul>\n<p>In the presence of <strong>≥ 2</strong> painless <strong>second trimester abortions</strong>, a <strong>history based diagnosis</strong> of <strong>cervical incompetence</strong> is made and the <strong>pregnant female</strong> can undergo <strong>prophylactic cervical cerclage</strong> with progesterone supplementation.</p>\n</div><hr><h3>Related Pearl: Mullerian Anomalies</h3><div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>Mullerian anomaly</strong></td>\n<td><strong>Reason/Feature</strong></td>\n<td><strong>Treatment</strong></td>\n<td><strong>Complications</strong></td>\n</tr>\n<tr>\n<td>I</td>\n<td><strong>Uterine hypoplasia or uterine agenesis</strong></td>\n<td>Underdeveloped or non-developed paramesonephric duct</td>\n<td>\n<ul>\n<li>Infertility treatment -surrogacy&nbsp;</li>\n<li>Vaginoplasty for vaginal hypoplasia</li>\n</ul>\n</td>\n<td>Infertility\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td><strong>Unicornuate uterus</strong></td>\n<td>Non-developed paramesonephric duct</td>\n<td>Excision of&nbsp;rudimentary horn, if any &nbsp;</td>\n<td>\n<ul>\n<li>Uterine rupture</li>\n<li>Abortions</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td><strong>Uterus didelphys</strong></td>\n<td>Unfused paramesonephric duct</td>\n<td>\n<p>Metroplasty- Resection of membrane and fundal recombination. This can be:</p>\n<ul>\n<li>Hysteroscopic</li>\n<li>Open e.g., Strassman metroplasty</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>IV</td>\n<td><strong>Bicornuate uterus&nbsp;</strong></td>\n<td>Lower part is fused whereas upper part is unfused</td>\n<td>Metroplasty in selected cases&nbsp;</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>V</td>\n<td><strong>Septate uterus&nbsp;</strong></td>\n<td>Septa of fused part persists</td>\n<td>Hysteroscopic septal resection&nbsp;</td>\n<td>\n<ul>\n<li>Infertility</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>VI</td>\n<td><strong>Arcuate uterus</strong></td>\n<td>A small indentation at upper part</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>VII</td>\n<td><strong>Diethylstillbesterone (DES), drug related</strong></td>\n<td>T-shaped uterus, shortened and narrow fallopian tubes, cervical collars (Cockscomb cervix)</td>\n<td>&nbsp;</td>\n<td>\n<ul>\n<li>Ectopic pregnancy</li>\n<li>Cervical incompetence</li>\n<li>Clear cell adenocarcinoma of cervix and vagina</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>A common complication is an abortion in the second trimester.</p>\n<p>Arcuate uterus: Some studies report no increase in adverse outcomes, whereas some studies have shown excessive second trimester loss, preterm labor and malpresentations.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b5daabaa46584f8ca9566b45a6d7c54dx1280x4923.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5269",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant female with known cardiac disease presents in the first trimester with history of warfarin embryopathy. What should be advised now?",
      "choices": [
        {
          "id": 1,
          "text": "Continue warfarin throughout the pregnancy"
        },
        {
          "id": 2,
          "text": "Replace warfarin with heparin in first trimester"
        },
        {
          "id": 3,
          "text": "Give acicoumarin"
        },
        {
          "id": 4,
          "text": "Use LMW heparin"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>In the <strong>first trimester</strong>, <strong>warfarin</strong> has to be <strong>replaced</strong> with <strong>heparin</strong> due to its potential teratogenic effects such as miscarriage, stillbirths, achondroplasia and stippled epiphyses.</p>\n<p>Low molecular weight heparin (LMWH) must replace warfarin and shouldn&rsquo;t be added along with the warfarin (Option D).</p>\n<p>The detailed guideline for anticoagulation in pregnancy is as follows:</p><table>\n<tbody>\n<tr>\n<td>Period of pregnancy</td>\n<td>Anticoagulation of choice</td>\n</tr>\n<tr>\n<td>First trimester</td>\n<td>\n<p>If dose of warfarin &lt; 5mg/day&ndash; continue warfarin till 36 weeks</p>\n<p>If dose of warfarin &gt; 5mg /day or warfarin embryopathy &ndash; replace it with heparin / LMWH</p>\n</td>\n</tr>\n<tr>\n<td>From 12 weeks to 36 weeks</td>\n<td>warfarin</td>\n</tr>\n<tr>\n<td>At 36 weeks</td>\n<td>Switch to LMWH</td>\n</tr>\n<tr>\n<td>1 week before EDD / 3 days before EDD</td>\n<td>Switch to UFH (as LMWH have longer T1/2&ndash; chances of PPH)</td>\n</tr>\n<tr>\n<td>On the day of delivery</td>\n<td>Stop all anticoagulantS</td>\n</tr>\n<tr>\n<td>6 hrs after vaginal delivery / 6-12 hrs after cesarean&nbsp;&nbsp;</td>\n<td>Restart UFH and warfarin.When INR is 2.5 to 3 withdraw UFH &amp; continue warfarin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<ul>\n<li>LMWH: low molecular weight heparin</li>\n<li>EDD: expected date of delivery</li>\n<li>UFH: unfractionated heparin</li>\n<li>PPH: postpartum hemorrhage</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5265",
      "difficulty": "easy"
    },
    {
      "text": "A 25-year-old lady with submucosal fibroid was undergoing myomectomy. The surgeon was using 1.5% glycine as irrigating fluid for the cavity. During the surgery, the nurse informs that there is a 500ml deficit of the irrigating fluid. What is the next step to be done?",
      "choices": [
        {
          "id": 1,
          "text": "Stop the surgery"
        },
        {
          "id": 2,
          "text": "Change the fluid to normal saline"
        },
        {
          "id": 3,
          "text": "Continue the surgery with careful monitoring of fluid status"
        },
        {
          "id": 4,
          "text": "Give furosemide to the patient and continue surgery"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This is a young patient with <strong>no comorbidities</strong>, subjected to an <strong>electrolyte poor fluid</strong> for irrigation. Since the deficit is&nbsp;<strong>500 mL,</strong>&nbsp;it is recommended to <strong>continue the surgery</strong> with careful <strong>monitoring of fluid status</strong>.</p>\n<p>The <strong>criteria for terminating the procedure</strong> for</p>\n<ul>\n<li>Electrolyte <strong>deficient</strong> fluid is&mdash;- a <strong>deficit </strong>of<strong> 1 L</strong></li>\n<li>Electrolyte <strong>rich</strong> fluid is&mdash;-- a <strong>deficit</strong> of <strong>2.5 L</strong></li>\n</ul>\n<p>Glycine irrigation causes <strong>hyponatremia</strong>. The&nbsp;<strong>earliest symptom</strong>&nbsp;of hyponatremia is <strong>nausea</strong> which typically requires fluid absorption (deficit) of at least&nbsp;<strong>1000 mL</strong>&nbsp;in women undergoing surgical procedures.</p>\n<p>There are two types of distension medias</p><table>\n<tbody>\n<tr>\n<td>Electrolyte deficient fluid</td>\n<td>Electrolyte rich media</td>\n</tr>\n<tr>\n<td>\n<ul>\n<li aria-level=\"1\">1.5% glycine</li>\n<li aria-level=\"1\">3% sorbitol</li>\n<li aria-level=\"1\">5% mannitol</li>\n</ul>\n</td>\n<td>\n<ul>\n<li aria-level=\"1\">Ringer lactate</li>\n<li aria-level=\"1\">Normal saline&nbsp;</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Instruments</strong> that can be used-</p>\n<p>monopolar / bipolar instruments</p>\n</td>\n<td>Only bipolar instruments</td>\n</tr>\n<tr>\n<td><strong>Complications:</strong>\n<ul>\n<li aria-level=\"1\">Water intoxication</li>\n<li aria-level=\"1\">Hyponatremia (except mannitol)</li>\n</ul>\n</td>\n<td>\n<ul>\n<li aria-level=\"1\">Causes Shock &amp; burns when used with monopolar instruments</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5263",
      "difficulty": "medium"
    },
    {
      "text": "The most important marker of male fertility in semen analysis is?",
      "choices": [
        {
          "id": 1,
          "text": "Morphology"
        },
        {
          "id": 2,
          "text": "Concentration"
        },
        {
          "id": 3,
          "text": "Motility"
        },
        {
          "id": 4,
          "text": "Sperm Count"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Morphology&nbsp;</strong>of sperms&nbsp;is the <strong>most important marker</strong> of <strong>male</strong> fertility.</p>\n<p>While&nbsp;sperm concentration and progressive motility have value for distinguishing infertile men, strict <strong>sperm morphology</strong>&nbsp;is the&nbsp;<strong>most important discriminating value&nbsp;</strong>compared toother parameters.</p><hr><h3>Related Pearl: Semen Analysis : WHO Criteria (2022)</h3><p><strong>Criteria, Normal values, Lowest reference limits (in brackets)</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Semen analysis </strong></td>\n<td><strong>Normal reference value and minimal reference (in parenthesis) limit</strong></td>\n</tr>\n<tr>\n<td>Volume</td>\n<td>2ml or more (1.4ml)</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.2-7.8</td>\n</tr>\n<tr>\n<td>Viscosity</td>\n<td>Less than 3</td>\n</tr>\n<tr>\n<td>Sperm concentration</td>\n<td>20 million/ml (15 million/ml)</td>\n</tr>\n<tr>\n<td>Total sperm count</td>\n<td>More than 40 million/ejaculate</td>\n</tr>\n<tr>\n<td>Motility</td>\n<td>More than 50% progressive forward motility(Progressive motility = 30%)</td>\n</tr>\n<tr>\n<td>Morphology</td>\n<td>More than 4% normal form (lower reference limit)</td>\n</tr>\n<tr>\n<td>Forward progression</td>\n<td>&gt;2 (Scale of 0-4)</td>\n</tr>\n<tr>\n<td>Viability</td>\n<td>54% or more living</td>\n</tr>\n<tr>\n<td>Leucocytes</td>\n<td>Less than 1 million/ml</td>\n</tr>\n<tr>\n<td>Round cells</td>\n<td>Less than 5 million/ml</td>\n</tr>\n<tr>\n<td>Sperm agglutination</td>\n<td>Less than 10 spermatozoa with adherent particles (&lt;2)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5262",
      "difficulty": "easy"
    },
    {
      "text": "A 20 year old girl presents with primary amenorrhea. On examination breasts were found to be poorly developed, vagina was present. Ultrasound revealed normal uterus but gonads weren’t detected. Further evaluation done showed 46XY karyotype. The most probable diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Androgen insensitivity syndrome"
        },
        {
          "id": 2,
          "text": "Turner syndrome"
        },
        {
          "id": 3,
          "text": "True hermaphrodite"
        },
        {
          "id": 4,
          "text": "Swyer's syndrome"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario of a <strong>46 XY</strong> individual with <strong>female internal &amp; external genitalia</strong> and <strong>poorly developed breasts,</strong> presenting with <strong>primary amenorrhea</strong> points towards the diagnosis of <strong>sweyer’s syndrome.</strong></p>\n<p><strong>Turner syndrome</strong> (option B) is a disorder of <strong>45 XO</strong> individuals with <strong>short stature</strong>. The gonads in these individuals are <strong>streak ovaries.</strong></p>\n<p><strong>Androgen Insensitivity Syndrome</strong> (option A) is a disorder of <strong>46 XY</strong> individuals with complete insensitivity to testosterone. These individuals have <strong>female external genitalia</strong> with an <strong>absent uterus.</strong> Secondary sexual characteristics like the development of <strong>breasts are adequate.</strong> However,<strong>pubic</strong> and <strong>axillary hairs</strong> are <strong>scanty.</strong></p>\n<p><strong>True hermaphrodite</strong> (option C) can be a <strong>46 XX</strong> or<strong> 46 XY</strong> individual with <strong>both ovaries and testis.</strong> These individuals have both <strong>male and female internal genitalia</strong> with <strong>ambiguous external genitalia.</strong></p>\n<p>Sweyer’s syndrome is a type of male pseudohermaphroditism where there is an <strong>inactivation of the SRY gene</strong> that leads to formation of <strong>dysgenetic testis.</strong></p>\n<p>Thus,in the absence of hormones; <strong>AMH &amp; testosterone</strong> the <strong>mullerian duct grows</strong> and the <strong>wolffian duct regresses</strong> forming female internal genitalia such as <strong>uterus</strong> (infantile type).</p>\n<p>These patients also lack the <strong>DHT hormone</strong> and hence present with poorly developed breasts ( tanner staging 1 or 2), <strong>scanty pubic,axillary hair</strong> and <strong>female external genitalia</strong>. These individuals are of <strong>normal stature</strong> with <strong>increased LH &amp; FSH.</strong></p>\n<p>Management includes <strong>gonadectomy as soon as diagnosed</strong> and <strong>estrogen + progesterone</strong> for breast development.</p>\n<p>AMH: Anti mullerian hormone<br />DHT: dihydro testosterone</p><hr><h3>Related Pearl: Disorders of Sexual Development</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Complete androgen insensitivity</strong></p>\n</td>\n<td>\n<p><strong>Mullerian agenesis</strong></p>\n</td>\n<td>\n<p><strong>Turner syndrome</strong></p>\n</td>\n<td>\n<p><strong>Complete XY dysgenesis (Swyer syndrome)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cause</strong></p>\n</td>\n<td>\n<p>X-linked mutation of androgen receptor</p>\n</td>\n<td>\n<p>Hypoplastic or absent Mullerian ductal system</p>\n<p><strong>Also called Mayer-Rokitansky-K&uuml;ster-Hauser&nbsp;syndrome</strong></p>\n</td>\n<td>\n<p>Complete or partial absence of one X chromosome</p>\n</td>\n<td>\n<p>SRY gene mutation on the Y chromosome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Reproductive organs</strong></p>\n</td>\n<td>\n<p>Absent uterus and upper vagina, cryptorchid testis</p>\n</td>\n<td>\n<p>Absent or rudimentary uterus and upper vagina, normal ovaries</p>\n</td>\n<td>\n<p>Normal uterus and vagina, streak gonads</p>\n</td>\n<td>\n<p>Normal uterus and vagina, streak gonads</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Breast</strong></p>\n</td>\n<td>\n<p>Yes</p>\n</td>\n<td>\n<p>Yes</p>\n</td>\n<td>\n<p>Variable</p>\n</td>\n<td>\n<p>No</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Axillary/</strong><strong>Pubic hair</strong></p>\n</td>\n<td>\n<p>Minimal to absent</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Minimal to absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Karyotype</strong></p>\n</td>\n<td>\n<p>46 XY</p>\n</td>\n<td>\n<p>46 XX</p>\n</td>\n<td>\n<p>45 XO or&nbsp;</p>\n<p>45 X mosaicism</p>\n</td>\n<td>\n<p>46 XY</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Note:&nbsp;</p>\n<p>Turner's syndrome have different chromosomal anomalies:</p>\n<ul>\n<li>45 XO which is seen in 40-50% patients&nbsp;</li>\n<li>45 X mosaicism (eg,&nbsp;<span class=\"nowrap\">45,X/46,XX&nbsp;</span>or&nbsp;<span class=\"nowrap\">45,X/47,XXX,</span>&nbsp;or 45,X mosaics with the X chromosome anomalies)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5259",
      "difficulty": "medium"
    },
    {
      "text": "The results of semen analysis of a young male have been given below. What is the diagnosis?\n5 million/ml concentration, 50% motility, 4% normal morphology",
      "choices": [
        {
          "id": 1,
          "text": "Oligospermia"
        },
        {
          "id": 2,
          "text": "Teratozoospermia"
        },
        {
          "id": 3,
          "text": "Asthenozoospermia"
        },
        {
          "id": 4,
          "text": "Oligoasthenoteratozoospermia"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given scenario of <strong>decreased sperm concentration</strong> with <strong>normal range</strong> of motility and morphology points to the diagnosis of <strong>oligospermia</strong>.</p>\n<p><strong>Oligospermia</strong> is defined as sperm concentration of <strong>&lt;15 million/ml.</strong><br />It is further subdivided into mild-moderate oligospermia when the concentration is 10-15 million sperms /ml &amp; <strong>severe oligospermia</strong> when the concentration is <strong>&lt;5 million sperms/ml</strong>.</p>\n<p><strong>Teratozoospermia</strong> or teratospermia (option B) is defined as Increased proportion of <strong>morphologically abnormal sperms</strong>.</p>\n<p><strong>Asthenozoospermia</strong> or asthenospermia (option C) is used to define sperms with <strong>diminished motility.</strong></p><table>\n<tbody>\n<tr>\n<td>Term&nbsp;</td>\n<td>definition</td>\n</tr>\n<tr>\n<td>azoospermia</td>\n<td>Semen with absent sperms</td>\n</tr>\n<tr>\n<td>aspermia</td>\n<td>Both semen and sperms are absent</td>\n</tr>\n<tr>\n<td>leukocytospermia</td>\n<td>Increased WBC count in the semen</td>\n</tr>\n<tr>\n<td>necrospermia</td>\n<td>Nonviable sperms</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Semen Analysis : WHO Criteria (2022)</h3><p><strong>Criteria, Normal values, Lowest reference limits (in brackets)</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Semen analysis </strong></td>\n<td><strong>Normal reference value and minimal reference (in parenthesis) limit</strong></td>\n</tr>\n<tr>\n<td>Volume</td>\n<td>2ml or more (1.4ml)</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.2-7.8</td>\n</tr>\n<tr>\n<td>Viscosity</td>\n<td>Less than 3</td>\n</tr>\n<tr>\n<td>Sperm concentration</td>\n<td>20 million/ml (15 million/ml)</td>\n</tr>\n<tr>\n<td>Total sperm count</td>\n<td>More than 40 million/ejaculate</td>\n</tr>\n<tr>\n<td>Motility</td>\n<td>More than 50% progressive forward motility(Progressive motility = 30%)</td>\n</tr>\n<tr>\n<td>Morphology</td>\n<td>More than 4% normal form (lower reference limit)</td>\n</tr>\n<tr>\n<td>Forward progression</td>\n<td>&gt;2 (Scale of 0-4)</td>\n</tr>\n<tr>\n<td>Viability</td>\n<td>54% or more living</td>\n</tr>\n<tr>\n<td>Leucocytes</td>\n<td>Less than 1 million/ml</td>\n</tr>\n<tr>\n<td>Round cells</td>\n<td>Less than 5 million/ml</td>\n</tr>\n<tr>\n<td>Sperm agglutination</td>\n<td>Less than 10 spermatozoa with adherent particles (&lt;2)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5257",
      "difficulty": "medium"
    },
    {
      "text": "A woman presents with prolonged labor in emergency. She is being taken for Cesarean section. Which of the following is the correct position in which the nurse should keep the patient on the OT table?",
      "choices": [
        {
          "id": 1,
          "text": "Supine with wedge under right hip"
        },
        {
          "id": 2,
          "text": "Semi fowlers"
        },
        {
          "id": 3,
          "text": "Trendelenburg with legs stirrup"
        },
        {
          "id": 4,
          "text": "Prone position"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The position of the patient in the Cesarean section is <strong>supine</strong>, with a <strong>wedge under the right hip.</strong></p>\n<p>The wedge beneath the right hip creates a <strong>left lateral tilt</strong> to <strong>aid venous return</strong> and <strong>avoid hypotension.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5270",
      "difficulty": "medium"
    },
    {
      "text": "A woman with 31 weeks of gestation presents with lower abdominal pain. The clinician is concerned if the patient is in preterm labor. Which of the following is the most appropriate test in this scenario?",
      "choices": [
        {
          "id": 1,
          "text": "Alpha fetoprotein"
        },
        {
          "id": 2,
          "text": "Beta HCG"
        },
        {
          "id": 3,
          "text": "Fetal fibronectin"
        },
        {
          "id": 4,
          "text": "PAPP-A"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Fibronectin</strong> detection in <strong>cervicovaginal </strong>secretions <strong>before membrane rupture</strong> is a possible marker for <strong>impending preterm labor.</strong></p>\n<p>Fetal fibronectin:</p>\n<ul>\n<li>Fetal fibronectin is a <strong>glycoprotein</strong> present in high concentrations in maternal blood and in <strong>amniotic fluid</strong>.</li>\n<li>Fetal fibronectin levels are measured using ELISA, and values <strong>exceeding 50 ng/mL</strong> are considered <strong>positive.</strong></li>\n</ul>\n<p>Screening tests in pregnancy:</p>\n<p><strong>1st Trimester:</strong></p>\n<p>Dual test + nuchal translucency</p><table>\n<tbody>\n<tr>\n<td>DUAL test</td>\n<td>Down&rsquo;s syndrome</td>\n<td>Trisomy 18</td>\n</tr>\n<tr>\n<td>PAPP-A (pregnancy associated plasma protein A)</td>\n<td>&darr;</td>\n<td>&darr;</td>\n</tr>\n<tr>\n<td>&beta;-HCG</td>\n<td>&uarr;</td>\n<td>&darr;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><p>2nd Trimester:</p>\n<table>\n<tbody>\n<tr>\n<td>Quadraple test</td>\n<td>Down&rsquo;s syndrome</td>\n<td>Trisomy 18</td>\n</tr>\n<tr>\n<td>&alpha; feto protein</td>\n<td>&darr;</td>\n<td>&darr;</td>\n</tr>\n<tr>\n<td>&beta;-HCG</td>\n<td>&uarr;</td>\n<td>&darr;</td>\n</tr>\n<tr>\n<td>Estriol (unconjugated E3)</td>\n<td>&darr;</td>\n<td>&darr;</td>\n</tr>\n<tr>\n<td>Inhibin A</td>\n<td>&uarr;</td>\n<td>&darr;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Integrated screening:<br />Dual screening + nuchal translucency + quad test</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5255",
      "difficulty": "easy"
    },
    {
      "text": "Identify the procedure done in the labor room?",
      "choices": [
        {
          "id": 1,
          "text": "Amniocentesis"
        },
        {
          "id": 2,
          "text": "MCA doppler"
        },
        {
          "id": 3,
          "text": "Cardiotocography"
        },
        {
          "id": 4,
          "text": "Amniotic fluid index determination"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given procedure is <strong>cardiotocography</strong> (CTG; electronic fetal monitor).</p>\n<p>CTG, is a type of <strong>intrapartum fetal monitoring</strong> where the <strong>fetal heartbeat</strong> and the <strong>uterine contractions</strong> are recorded <strong>simultaneously.</strong></p>\n<p>The CTG graph can be differentiated from non stress test (NST) graph by the presence of <strong>two graphical</strong> representations in <strong>CTG</strong>:</p>\n<ul>\n<li>FHR represented by the upper graph</li>\n<li>Uterine contractions represented by the lower graph.</li>\n</ul>\n<p><strong>NST</strong> has a <strong>single graphical</strong> representation.</p>\n<p>A <strong>normal CTG</strong> graph is defined by the following parameters:</p>\n<ul>\n<li>Baseline FHR-110-160</li>\n<li>Beat to beat variability of 5-25 bpm</li>\n<li>Two or more Acceleration during 20 minute period</li>\n<li>No late deceleration</li>\n<li>No variable deceleration</li>\n<li>Early deceleration +/-</li>\n</ul>\n<p>The below given depicts a <strong>CTG graph</strong></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/21cc641092bc419ca4b4b39b8467fb36.JPEG\" alt=\"Explanation Image\"><p>The below given image shows a NST graph</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/cc06e59b25454258b261207792b5c691x720x428.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Deceleration patterns on cardiotocography (CTG)</h3><p><strong>Early deceleration</strong>: seen in head compression</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/01ca2f6239b443139c19f8cfb251123fx720x612.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Late deceleration</strong>:&nbsp;Seen in uteroplacental insufficiency, foetal hypoxia</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d22f1efb031f427abc29cb814976ea47x468x323.JPEG\" alt=\"Pearl Image\"><p>&nbsp;</p>\n<p><strong>Variable</strong> <strong>deceleration</strong>: Seen in umbilical cord compression</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/034553eba0b7498882645a4cf156f0e0x468x399.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4b28c3a2392c4925966f7fd83948bd8b.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5256",
      "difficulty": "easy"
    },
    {
      "text": "A G3P2L0 presents with 9 weeks of amenorrhea. She has a history of conization being done one year ago and is currently on follow-up, with no recurrence on PAP smear. She also has the history of preterm labor at 30 and 32 weeks. What is the next step of management?",
      "choices": [
        {
          "id": 1,
          "text": "USG to see cervical length"
        },
        {
          "id": 2,
          "text": "Cervical Cerclage"
        },
        {
          "id": 3,
          "text": "Complete Bed rest"
        },
        {
          "id": 4,
          "text": "Abdominal cerclage"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The next step of management in this patient, is to do<strong> USG to measure the cervical length.</strong></p>\n<p>In the given clinical scenario the patient has undergone <strong>conization</strong> which is a <strong>risk factor</strong> for <strong>cervical incompetence</strong>. Hence, it is important to <strong>measure the cervical length</strong> to diagnose cervical incompetence in this patient. If the cervical length is <strong>≤2.5 cm </strong>then a cervical cerclage can be performed.</p>\n<p><strong>Cervical cerclage</strong> (Option B) is performed as the <strong>next</strong><strong> step</strong> in management when the patient presents with <strong>≥2 second trimester pregnancy losses </strong>(History based diagnosis of cervical incompetence). Since, the history in this patient is of preterm labour, the first step would still be to do a TVS to measure the cervical length for diagnosing. Cerclage only comes after diagnosis.</p>\n<p><strong>Cervical incompetence</strong> is one of the important causes second trimester (mid trimester) abortions.</p>\n<p>Risk factors for the incompetence include: </p>\n<ul>\n<li>Past h/o surgery on cervix such as conization, loop electrosurgical excision procedure (LEEP)</li>\n<li><strong>Cervical trauma</strong> during labour, instrumental delivery</li>\n</ul>\n<p>Diagnosis of cervical incompetence in a pregnant female:</p>\n<ul>\n<li>H/O <strong>≥2 second trimester abortions</strong> (history based diagnosis)→ management is by <strong>cervical cerclege+progesterone</strong></li>\n<li>H/O <strong>1 second trimester abortion</strong>→ <strong>TVS</strong> done between <strong>18-24 weeks</strong> to measure the cervical length→<strong>USG based diagnosis</strong> of cervical incompetence is made if there is<strong> h/o 1</strong> or more <strong>second trimester abortions</strong> with TVS showing <strong>cervical length ≤2.5 cm.</strong></li>\n</ul>\n<p>TVS findings in cervical incompetence include:</p>\n<ul>\n<li>Cervical length <strong>≤2.5 cm </strong>(Normal:3-4cm)</li>\n<li>Shape of cervix becomes <strong>U shaped</strong></li>\n<li>Diameter of internal os<strong> ≥ 2cm</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5253",
      "difficulty": "medium"
    },
    {
      "text": "What is the minimum endometrial thickness on transvaginal ultrasonography, above which you perform a biopsy in a case of postmenopausal bleeding?",
      "choices": [
        {
          "id": 1,
          "text": "3mm"
        },
        {
          "id": 2,
          "text": "4mm"
        },
        {
          "id": 3,
          "text": "7mm"
        },
        {
          "id": 4,
          "text": "9mm"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>A finding of endometrial thickness <strong>&ge;&nbsp;4 mm </strong>(according to ACOG)<strong>&nbsp;</strong>in a <strong>postmenopausal women</strong>&nbsp;requires further evaluation, such as endometrial biopsy.</p>\n<p>If the endometrial thickness is <strong>&le;4 mm</strong> in a <strong>post menopausal female</strong>, malignancy is rare and hence, can be managed by <strong>tranexamic acid</strong>. If the <strong>bleeding</strong> still <strong>persists</strong>, the patient needs to undergo <strong>fractional curettage and hysteroscopy.</strong></p>\n<p>The algorithm for <strong>next step</strong> for <strong>abnormal uterine bleeding</strong> in different age groups is as follows:</p><table>\n<tbody>\n<tr>\n<td>&nbsp;Age group</td>\n<td>Endometrial thickness on TVS</td>\n<td>Action</td>\n</tr>\n<tr>\n<td>Age &lt;40years</td>\n<td>&nbsp;&gt;12mm</td>\n<td>Endometrial sampling/Endometrial biopsy</td>\n</tr>\n<tr>\n<td>Age&gt;40 years or Age &gt;45 years</td>\n<td>-</td>\n<td>Endometrial sampling/Endometrial biopsy is done irrespective of usg findings</td>\n</tr>\n<tr>\n<td>Post menopausal women</td>\n<td>&ge;4mm</td>\n<td>&nbsp;Endometrial sampling/Endometrial biopsy</td>\n</tr>\n<tr>\n<td>Post menopausal women</td>\n<td>&lt;4mm</td>\n<td>\n<ul>\n<li>Reassurance+tranexamic acid</li>\n<li>If, bleeding still persists then do endometrial biopsy</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/acac31efbf3e49dca75bdc3081987821x1280x2320.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5254",
      "difficulty": "easy"
    },
    {
      "text": "A patient has been on MALA-N for 6 months. She is compliant, but she complained of missed periods. What is the next step?",
      "choices": [
        {
          "id": 1,
          "text": "Transvaginal ultrasound"
        },
        {
          "id": 2,
          "text": "Reassure her that it’s normal to have delayed period"
        },
        {
          "id": 3,
          "text": "Beta HCG estimation"
        },
        {
          "id": 4,
          "text": "Serum FSH and LH"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the event of <strong>missed periods</strong> while on contraceptives, <strong>Beta-HCG</strong> estimation should be done as the next step <strong>to rule out</strong> <strong>pregnancy</strong>.</p>\n<p>Serum beta HCG can detect a pregnancy as early as <strong>5 days </strong>before the first missed period. This can be done by either <strong>serum</strong> <strong>beta hcg estimation</strong> or by <strong>urine pregnancy test</strong> which estimates the beta-hcg excreted in urine. If the patient is not pregnant she can continue taking the combined pill.</p>\n<p>Mala N is a combined oral contraceptive pill that is distributed for free by the Indian government. It contains <strong>0.15 mg</strong> levonorgestrel and <strong>30 &micro;g</strong>&nbsp;ethinyl estradiol. It contains <strong>21 contraceptive pills + 7 iron tablets</strong>. It is started on the first day of each cycle.</p>\n<div class=\"page\" title=\"Page 275\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The combined oral pills act by suppressesing pituitary hormones and preventing ovulation. The progestogen also causes atrophic changes in the endometrium and prevents implantation. It also causes thickening of the cervical mucus, making it difficult for the sperms to penetrate.</p>\n<p>The menstrual side efects includes breakthrough bleeding, menorrhagia and rarely post-pill amenorrhea when the patient is on drug for more than 6 months. Post pill amenorrhea is seen in &lt;1% of patients and should be considered only after ruling out pregnancy.</p>\n</div>\n</div>\n</div>\n<p>Pregnancy rate with the combined oral pill is <strong>0.1 per 100 woman-years.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5260",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant woman delivered a baby with the normal expulsion of an intact placenta. After half an hour she started bleeding per vaginal. On examination, she was hypotensive and a boggy mass was palpated per abdomen. USG showed retained placental tissues. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Placenta membranacea"
        },
        {
          "id": 2,
          "text": "Placenta succenturiata"
        },
        {
          "id": 3,
          "text": "Circummarginate placenta"
        },
        {
          "id": 4,
          "text": "Circumvallate placenta"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The reason for the <strong>postpartum hemorrhage</strong> in the given patient is likely due to the <strong><span id=\"mark_text_0\" class=\"highlightedCurrent\">succenturiate</span> lobe</strong> being torn away and <strong>left behind </strong>at the time of <strong>placental delivery, </strong>as seen with cases of <strong>Placenta succenturiata</strong>.</p>\n<p><strong>Placenta succenturiata</strong> refers to the abnormal placenta where an <strong><span class=\"nowrap\">additional lobe/</span>lobes</strong> of placental tissue are located <strong>a few centimeters away</strong>. The <strong>ancillary lobes</strong> are <strong>smaller in size</strong> when compared with the main placental tissue (note: Bilobed placenta has two lobes of equal sizes).These lobes have <strong>vessels</strong> that course through the membranes <strong>connecting</strong> them to the <strong>main placental tissue.</strong></p>\n<p><strong>Placenta succenturiata </strong>can be associated with complications like <strong>vasa previa </strong>(fetal hemorrhage), <strong>postpartum hemorrhage</strong> due to <strong>retained placental tissues, </strong>infection such as <strong>endometritis, </strong><strong>Subinvolution</strong> of uterus and Placental <strong>polyp</strong> formation.</p>\n<p>An image of this variant is given below where L1,2,3 depicts smaller lobes, UC is the umbilical cord, and M is the intervening membrane. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f645bab62b6a420cbbecea44278821e8x512x624.PNG\" alt=\"Explanation Image\"><p>The below given image shows a <strong>Bilobed</strong> or <strong>Bipartite</strong> or <strong>duplex</strong> placenta which is different from placenta succenturiata. The lobes in bilobed placenta are nearly equal in size. The umbilical cord is attached into a connecting chorionic bridge or into the interven­ing membranes in between the two placental lobes.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/da5aba60caec4551923664d43e7d2187.PNG\" alt=\"Explanation Image\"><p>Other options:</p>\n<p>Option A: <strong>Placenta membranacea </strong>is an unduly <strong>large</strong> and<strong> thin placenta</strong> that develops from <strong>both</strong> the <strong>chorionic frondosum</strong> and<strong> the chorion leave</strong>. It is associated with an increased risk of <strong>placenta previa</strong> or <strong>accreta</strong> and <strong>retained placenta</strong> and its complications.</p>\n<p><strong>Circummarginate placenta</strong> (option C) and <strong>Circumvallate</strong> placenta (option D) are a type of <strong>extrachorial placentation.</strong></p>\n<p>In <strong>extrachorial </strong>placentation, the <strong>chorionic plate is smaller </strong>than the basal plate.The chorionic plate does not extend upto the placental margin. The membranes (amnion and chorion) are rolled back upon themselves to form a ring leaving a rim of bare placental tissue (extrachorial portion)</p>\n<p><strong>Circummarginate</strong> placenta-A thin <strong>fibrous ring</strong> is present at the margin of the chorionic plate where the fetal vessels appear to terminate.</p>\n<p>Circumvallate placenta - The fetal surface is divided into a <strong>central depressed zone</strong> surrounded by a <strong>thickened ring</strong> which is composed of a double fold of amnion and chorion. Vessels radiate from the cord insertion as far as the ring and then disap­pear from the view.</p>\n<p><strong>Complications</strong> associated with<strong> circumvallate</strong> placenta are preterm delivery, abortions, growth retardation, antepartum hemorrhage, retained placenta, and hydrorrhea gravidarum.</p>\n<p>A specimen of circumvallate placenta is shown below:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4a96dcd5a70f487b8cfd2201ca8e9279x1279x1206.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC5258",
      "difficulty": "easy"
    },
    {
      "text": "HPV nonavalent vaccine is active against which of the following serotypes?",
      "choices": [
        {
          "id": 1,
          "text": "6, 11, 16, 18, 20, 23, 35, 42, 52"
        },
        {
          "id": 2,
          "text": "6, 11, 16, 19, 23, 33, 45, 58"
        },
        {
          "id": 3,
          "text": "6, 11, 16, 18, 32, 34, 45, 52, 58"
        },
        {
          "id": 4,
          "text": "6, 11, 16, 18, 31, 33, 45, 52, 58"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>HPV <strong>nonavalent</strong> vaccine (<strong>Gardasil 9 or HPV9</strong>) is active against <strong>HPV 6,11,16,18,31,33,45,52,58.</strong></p>\n<p>Currently, HPV nonnavalent vaccine has replaced <strong>Gardasil</strong> which is a <strong>quadrivalent</strong> vaccine acting against <strong>6,11,16,18.</strong></p>\n<p>Vaccines available for HPV:&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Brand name</strong></td>\n<td><strong>Cervarix</strong></td>\n<td><strong>Gardasil</strong></td>\n<td><strong>Gardasil-9</strong></td>\n<td>&nbsp;<strong data-stringify-type=\"bold\">Cervavac</strong></td>\n</tr>\n<tr>\n<td>Characteristic and HPV subtypes</td>\n<td>Bivalent:<strong>16,18</strong></td>\n<td>Quadrivalent: <strong>6,11,16,18</strong></td>\n<td>Nonavalent: <strong>6,11,16,18,31,33,45,52,58</strong></td>\n<td>&nbsp;Quadrivalent: <strong>6,11,16,18</strong></td>\n</tr>\n<tr>\n<td>Protects against:</td>\n<td>\n<ul>\n<li>CIN</li>\n<li>CA cervix</li>\n</ul>\n</td>\n<td>\n<ul>\n<li><strong>Anogenital warts</strong></li>\n<li>CIN</li>\n<li>CA cervix</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Anogenital warts</li>\n<li>CIN</li>\n<li>CA cervix &nbsp;</li>\n<li><strong>Vulval </strong>intraepithelial<strong> neoplasia</strong></li>\n<li><strong>Vaginal </strong>intraepithelial<strong> neoplasia</strong></li>\n<li><strong>Anal cancer</strong></li>\n<li><strong>Oropharyngeal cancer</strong></li>\n<li><strong>Head and neck cancers</strong></li>\n</ul>\n</td>\n<td>\n<ul>\n<li><strong>Anogenital warts</strong></li>\n<li>CIN</li>\n<li>CA cervix</li>\n</ul>\n&nbsp;</td>\n</tr>\n<tr>\n<td>Dose</td>\n<td><strong>0.5 ml</strong>, <strong>IM</strong>.</td>\n<td><strong>0.5 ml</strong>, <strong>IM</strong>.</td>\n<td><strong>0.5 ml</strong>, <strong>IM</strong>.</td>\n<td>&nbsp;<strong>0.5 ml</strong>, <strong>IM</strong>.</td>\n</tr>\n<tr>\n<td>Ideal Age range:</td>\n<td>\n<p>Ideally at 11-12 years or</p>\n<p>9-26 years&nbsp;</p>\n</td>\n<td>\n<p>Ideally at 11-12 years or</p>\n<p>9-26 years&nbsp;</p>\n</td>\n<td>\n<p>Ideally at 11-12 years or</p>\n<p>9-26 years&nbsp;</p>\n</td>\n<td>\n<p>The targeted age group is 9-26 years</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><div class=\"row mt-3\">As per the&nbsp;<strong data-stringify-type=\"bold\">December 2022 WHO&nbsp;</strong>updated dose schedules on<strong data-stringify-type=\"bold\">&nbsp;HPV vaccines,</strong>&nbsp;the recommendations for different age groups are as follows:</div>\n<div class=\"row mt-3\">\n<div class=\"row mt-3\">\n<ul>\n<li><strong>1 or 2 doses</strong>&nbsp;scheduled<strong>&nbsp;</strong>for the primary target of girls aged&nbsp;<strong>9&ndash;14 years</strong>.</li>\n<li><strong>1 or 2 doses</strong>&nbsp;scheduled&nbsp;for young women aged&nbsp;<strong>15&ndash;20 years</strong>.</li>\n<li><strong>2</strong>&nbsp;doses with a&nbsp;<strong>6-month interval</strong>&nbsp;for women&nbsp;<strong>older than 21 years</strong>.</li>\n<li>\n<div class=\"p-rich_text_section\">A minimum of<strong data-stringify-type=\"bold\">&nbsp;2 doses</strong>&nbsp;and when feasible <strong>3 doses</strong>&nbsp;remain necessary for those known to be<strong data-stringify-type=\"bold\">&nbsp;immunocompromised </strong>and/or<strong data-stringify-type=\"bold\"> HIV-infected</strong>.</div>\n</li>\n</ul>\n</div>\n</div><hr><h3>Related Pearl: Human Papilloma Virus (HPV) and Associated Lesions</h3><table>\n<tbody>\n<tr>\n<td><strong>HPV serotype</strong></td>\n<td><strong>Lesions</strong></td>\n</tr>\n<tr>\n<td>HPV 1,2,3,4</td>\n<td>\n<div class=\"page\" title=\"Page 566\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Common warts (verruca vulgaris, plantar wart)</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>HPV 6 and 11</td>\n<td>\n<ul>\n<li>Condyloma acuminatum (genital warts)</li>\n<li>Sinonasal papilloma</li>\n<li>Squamous papilloma of the larynx</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HPV 16</td>\n<td>\n<ul>\n<li>LSIL, HSIL, carcinoma cervix</li>\n<li>Vulval carcinoma</li>\n<li>Bowen disease (Carcinoma in situ of male external genitalia)</li>\n<li>Oropharyngeal squamous cell carcinoma</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HPV 18</td>\n<td>\n<ul>\n<li>LSIL, HSIL, Carcinoma of the cervix</li>\n<li>Carcinoma of the anogenital region</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>HPV 5 and 8</td>\n<td>\n<ul>\n<li>Squamous cell carcinoma of the skin in epidermodysplasia verruciformis patients</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>LSIL: Low-grade squamous intraepithelial lesion</p>\n<p>HSIL: High-grade squamous intraepithelial lesion&nbsp;&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9222",
      "difficulty": "easy"
    },
    {
      "text": "Sentinel lymph node biopsy is most useful in which of the following gynecological malignancies?",
      "choices": [
        {
          "id": 1,
          "text": "Carcinoma vagina"
        },
        {
          "id": 2,
          "text": "Carcinoma vulva"
        },
        {
          "id": 3,
          "text": "Carcinoma cervix"
        },
        {
          "id": 4,
          "text": "Carcinoma endometrium"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<div class=\"page\" title=\"Page 492\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Among the given gynecological malignancies, <strong>sentinel lymph node biopsy</strong>&nbsp;(SLNB) is most useful in <strong>vulval</strong> <strong>carcinomas</strong>.</p>\n<p>This is because women with <strong>earlier stages</strong> of vulval cancer can have <strong>diseased lymph nodes</strong> even <strong>without palpable</strong> <strong>enlargement of nodes</strong>. Hence, sentinel lymph node biopsy helps in early diagnosis lymph node spread which can be managed by lymph node dissection.</p>\n<div class=\"page\" title=\"Page 710\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A <strong>sentinel lymph node</strong> is a physiologically, the <strong>first lymph node</strong> to receive tumor lymphatic drainage.</p>\n<p>Malignancies where <strong>sentinel lymph node biopsy</strong> is commonly done are :</p>\n<ul>\n<li><strong>Vulval carcinoma</strong></li>\n<li><strong>Breast carcinoma</strong></li>\n<li><strong>Penile carcinoma</strong></li>\n<li><strong>Malignant melanoma</strong></li>\n</ul>\n</div>\n</div>\n</div>\n<p>Lymphatic mapping is similar technique to SLNB that can also be used in vulval cancers.</p>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3734",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is not included in the active management of the third stage of labor to prevent postpartum hemorrhage?",
      "choices": [
        {
          "id": 1,
          "text": "Uterotonic within 1 minute of delivery"
        },
        {
          "id": 2,
          "text": "Delayed clamping, cutting and ligation of cord"
        },
        {
          "id": 3,
          "text": "Gentle massage of uterus"
        },
        {
          "id": 4,
          "text": "Controlled cord traction"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">As per the latest guidelines, <strong>uterine massage</strong> is <strong>no longer</strong> a <strong>core</strong> <strong>component</strong> of Active Management of the Third Stage of Labor (<strong>AMTSL</strong>) that is performed for the <strong>prevention of postpartum hemorrhage (PPH).</strong></p>\n<p class=\"ng-binding\"><strong>Uterine massage</strong>&nbsp;or fundal massage is <strong>not recommended </strong>as an intervention to <strong>prevent PPH</strong> in women who have already&nbsp;<strong>received</strong> prophylactic<strong> uterotonics</strong> such as oxytocin (core component of AMTSL). Hence, it is now an <strong>optional component </strong>of<strong> AMTSL&nbsp;</strong>that is&nbsp;done in&nbsp;patients with <strong>uterine</strong> <strong>atony</strong> as a part of the <strong>management of PPH.</strong></p>\n<p class=\"ng-binding\"><strong>AMTSL</strong>&nbsp;is recommended by the&nbsp;<strong>WHO</strong>&nbsp;to<strong> prevent postpartum hemorrhage </strong>(PPH).&nbsp;<strong>Uterotonics</strong> are the <strong>most important </strong>components in AMTSL to do so.</p>\n<p>The currently recommended components of AMTSL are as follows:</p>\n<table>\n<tbody>\n<tr>\n<td>1.</td>\n<td>Injecting <strong>uterotonics</strong> within <strong>1 minute</strong> of delivery of the baby or immediately after delivery of the <strong>anterior shoulder</strong></td>\n<td>\n<ul>\n<li><strong>Most important</strong> step</li>\n<li><strong>Oxytocin</strong> 10 IU im/iv infusion is the <strong>preferred uterotonic</strong>.</li>\n</ul>\n<p>(<strong>Not recommended</strong> by WHO- <strong>carboprost)</strong></p>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>2</td>\n<td><strong>Delayed cord clamping</strong></td>\n<td>\n<ul>\n<li>Done within <strong>1-3 mins</strong> of delivery</li>\n<li><strong>80 ml</strong> of additional blood goes to the fetus</li>\n<li><strong>Prevents</strong> <strong>fetal anemia</strong></li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>3</td>\n<td>Delivery of placenta by controlled cord traction: Modified Brandt Andrews technique</td>\n<td>\n<ul>\n<li>The uterus is pushed upwards and backward</li>\n<li>The traction of cord is downwards and forwards</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>4</td>\n<td>Intermittent assessment of uterine tone</td>\n<td>Done every 15 mins for 2 hours</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: In the event that <strong>uterine atony</strong> is diagnosed during the assessment of uterine tone, <strong>uterine massage</strong> can be performed to <strong>control PPH</strong>.</p>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6984",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following changes can be seen in the quadruple screening for Down syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Elevated β-hCG, PAPP-A and lower estriol, AFP"
        },
        {
          "id": 2,
          "text": "Elevated β-hCG, Inhibin and lower estriol, AFP"
        },
        {
          "id": 3,
          "text": "Lower β-hCG, PAPP-A and elevated estriol, AFP"
        },
        {
          "id": 4,
          "text": "Lower  β-hCG, Inhibin and elevated estriol, AFP"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Quadruple screening is a <strong>second-trimester</strong> multiple marker screening test used for the detection of <strong>chromosomal anomalies</strong> like Down syndrome. It is performed between <strong>15-21 weeks</strong>.</p>\n<p>Pregnancies with <strong>Down syndrome</strong> are characterized by<strong> elevated</strong> &beta;-hCG, <strong>elevated</strong> Inhibin A,&nbsp;<strong>reduced</strong> estriol and <strong>reduced&nbsp;</strong>AFP levels.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>&nbsp;</strong></td>\n<td><strong>Trisomy 21</strong></td>\n<td><strong>Trisomy 18</strong></td>\n<td><strong>Neural tube defect or abdominal wall defect</strong></td>\n</tr>\n<tr>\n<td><strong>MSAFP</strong></td>\n<td>Low</td>\n<td>Low</td>\n<td>High</td>\n</tr>\n<tr>\n<td><strong>&beta; hCG</strong></td>\n<td>High</td>\n<td>Low</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td><strong>Unconjugated estriol</strong></td>\n<td>Low</td>\n<td>Low</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td><strong>Inhibin A</strong></td>\n<td>High</td>\n<td>Low</td>\n<td>Normal</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>First-trimester aneuploidy screening</strong> combines two maternal serum analytes (<strong>Dual screening test</strong>) with a <strong>sonographic measurement</strong>.<strong> </strong>It is performed between <strong>11-14 weeks</strong>.</p>\n<table>\n<tbody>\n<tr>\n<td>Dual test</td>\n<td><strong>Down&rsquo;s syndrome</strong></td>\n<td><strong>Trisomy 18 &amp; Trisomy 13</strong></td>\n</tr>\n<tr>\n<td>PAPP-A (pregnancy associated plasma protein A)</td>\n<td>&darr;</td>\n<td>&darr;</td>\n</tr>\n<tr>\n<td>&beta;-HCG</td>\n<td>&uarr;</td>\n<td>&nbsp;&darr;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>An <strong>increased nuchal translucency</strong> indicates an <strong>increased possibility</strong> of <strong>Down's syndrome</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6347",
      "difficulty": "easy"
    },
    {
      "text": "All of the following can be indicators of choriocarcinoma except:",
      "choices": [
        {
          "id": 1,
          "text": "Increased number of theca lutein cysts"
        },
        {
          "id": 2,
          "text": "Persistently enlarged uterus"
        },
        {
          "id": 3,
          "text": "Plateau of high serum hCG"
        },
        {
          "id": 4,
          "text": "Suburethral nodule"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Increased number of theca lutein cysts is not an indicator of choriocarcinoma.<strong>&nbsp;Increased size&nbsp;</strong>or&nbsp;<strong>persistence&nbsp;</strong>of theca lutein cysts indicates <strong>choriocarcinoma</strong>.</p>\n<p>Plateau of high serum &beta;-hCG level&nbsp;for four measurements for&nbsp;&ge;3 weeks&nbsp;is an indicator of&nbsp;choriocarcinoma.</p>\n<p><strong>Risk factors</strong> for <strong>malignant</strong> change are:</p>\n<ul>\n<li>Molar pregnancy - complete moles have 15-20% risk, partial moles have 1-5% risk</li>\n<li>Patient's age&nbsp;&ge; 40 years or &lt;20 years</li>\n<li>Parity&nbsp;&ge;3</li>\n<li>Serum&nbsp;&beta; hCG &gt;1,00,000 IU/mL</li>\n<li>Uterine size &gt;20 weeks</li>\n<li>Previous history of molar pregnancy</li>\n<li>Large theca lutein cysts &gt;6 cm in diameter</li>\n</ul>\n<p>Post-evacuation uterine <strong>sonographic</strong> <strong>surveillance</strong> can be used as a <strong>predictor</strong> of subsequent <strong>neoplasia</strong>.&nbsp;Findings indicative of malignant transformation are:</p>\n<ul>\n<li><strong>Suburethral nodules</strong></li>\n<li>Myometrial nodules</li>\n<li><strong>Hypervascularity</strong>.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7142",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following hormones will be secreted in high amounts by the ovarian granulosa cells during the follicular phase of the menstrual cycle?",
      "choices": [
        {
          "id": 1,
          "text": "FSH"
        },
        {
          "id": 2,
          "text": "Estrogen"
        },
        {
          "id": 3,
          "text": "LH"
        },
        {
          "id": 4,
          "text": "Progesterone"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>During the <strong>follicular phase</strong> of the menstrual cycle, <strong>estrogen</strong> is secreted in high amounts by the ovarian <strong>granulosa cell</strong>.</p>\n<p><strong>Follicular phase (days 0&ndash;14)</strong></p>\n<ul>\n<li>A primordial follicle develops to the <strong>Graafian stage</strong>, with atresia of neighboring follicles.</li>\n<li>LH and FSH receptors are up-regulated in theca and granulosa cells.</li>\n<li><strong>Estradiol</strong> levels increase and cause the&nbsp;<strong>proliferation of the uterus.</strong></li>\n<li>FSH and LH levels are suppressed by the negative feedback effect of estradiol on the anterior pituitary.</li>\n<li>Progesterone levels are low.</li>\n</ul>\n<p><strong>Ovulation (day 14)</strong></p>\n<ul>\n<li>Occurs 14 days before menses, regardless of cycle length.</li>\n<li>A burst of estradiol synthesis at the end of the follicular phase has a positive feedback effect on the secretion of FSH and LH (<strong>LH surge</strong>).</li>\n<li><strong>Ovulation</strong> occurs as a result of the<strong> estrogen-induced LH surge</strong>.</li>\n<li>Estrogen levels decrease just after ovulation (but rise again during the luteal phase).</li>\n<li>Cervical mucus increases in quantity; it becomes less viscous and more penetrable by sperm.</li>\n</ul>\n<p><strong>Luteal phase (days 14&ndash;28)</strong></p>\n<ul>\n<li>The <strong>corpus luteum</strong> begins to develop, and it predominantly synthesizes <strong>progesterone</strong>. Vascularity and secretory activity of the endometrium increase to prepare for receipt of a fertilized egg.</li>\n<li><strong>Basal body temperature</strong>&nbsp;increases because of the effect of&nbsp;<strong>progesterone</strong>&nbsp;on the hypothalamic thermoregulatory center.</li>\n<li>If fertilization does not occur, the corpus luteum regresses at the end of the luteal phase. As a result, estradiol and progesterone levels decrease abruptly.</li>\n</ul>\n<p><strong>Menses (days 0&ndash;4)</strong></p>\n<ul>\n<li>The endometrium is sloughed because of the abrupt withdrawal of estradiol and progesterone</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/03eee65576bc4ebbb1a6014af707e458x600x655.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7146",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements is true regarding the instrument shown below?<div class='question-desc-html'><p>A. It is used in women not on thromboprophylaxis and planned for caesarean section.<br />B. It is used in women on thromboprophylaxis and planned for caesarean section.<br />C. It is removed once the patient starts ambulating.</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "A and B"
        },
        {
          "id": 2,
          "text": "B and C"
        },
        {
          "id": 3,
          "text": "A and C"
        },
        {
          "id": 4,
          "text": "Only C"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given image shows a <strong>pneumatic compression device.&nbsp;</strong>It is <strong>used in women</strong> who are <strong>not on</strong> any <strong>thromboprophylaxis</strong> and planned for cesarean section (statement A) and it is <strong>discontinued</strong> <strong>once</strong> the patient starts<strong> ambulating</strong> post-surgery (statement C).</p>\n<p>The device is used because <strong>pregnancy</strong> and <strong>surgery</strong> increase the <strong>risk</strong> of <strong>thromboembolism</strong>.</p>\n<p>According to recent guidelines, patients with <strong>no additional risk factors</strong> and <strong>not </strong>placed on any <strong>pharmacological</strong> <strong>thromboprophylaxis</strong> are placed on&nbsp;<strong>pneumatic compression devices</strong> before cesarean delivery. Patients undergoing cesarean delivery with <strong>additional risk factors</strong> are put on <strong>both</strong> pneumatic <strong>compression devices</strong> and <strong>pharmacological therapy</strong> (UFH or LMWH). UFH-unfractionated heparin, LMWH-lower molecular weight heparin.</p>\n<p><strong>Indications of pharmacological thromboprophylaxis:</strong></p>\n<ul>\n<li>Inherited coagulation disorder</li>\n<li>Overweight or obese patient<strong><br /></strong></li>\n<li>Heart failure</li>\n<li>Family history of deep vein thrombosis or pulmonary embolism</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/81959a2ab2bc41e4a07cfc0e437ec33b.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9873",
      "difficulty": "medium"
    },
    {
      "text": "A young female has history of a spontaneous abortion. She has had amenorrhea since then. Her FSH now is 6 mIU/ml. Which of the following can be a cause for her amenorrhea?",
      "choices": [
        {
          "id": 1,
          "text": "Pituitary dysfunction"
        },
        {
          "id": 2,
          "text": "Ovarian dysfunction"
        },
        {
          "id": 3,
          "text": "First pregnancy"
        },
        {
          "id": 4,
          "text": "Uterine synechiae"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The development of <strong>uterine synechiae</strong> is the most likely cause of amenorrhoea in the given clinical scenario.</p>\n<p>Certain types of <strong>spontaneous abortions</strong> such as <strong>inevitable, incomplete</strong> and <strong>missed abortions</strong> might require medical assistance for complete removal of products of conception including procedures such as <strong>dilatation and curettage.</strong></p>\n<p><strong>Vigorous uterine curettage</strong> in early pregnancy <strong>damages the basal layer of endometrium</strong> leading to scarring and adhesions in the uterus that interferes with normal endometrial growth and shedding.This causes the clinical feature of <strong>secondary amenorrhea</strong> as seen in this patient.</p>\n<p>This <strong>intrauterine adhesions</strong> are known as <strong>uterine synechiae</strong> or <strong>Asherman syndrome.</strong></p>\n<p>As there is <strong>no defect</strong> in the <strong>hypothalamo-pituitary-ovarian axis</strong> in the <strong>asherman syndrome</strong>, the levels of <strong>FSH</strong> remain within the <strong>normal range</strong> of 4 - 25 IU/L as seen in this patient.</p>\n<p>In the case of <strong>Pituitary dysfunction</strong> (option A) the <strong>FSH levels</strong> are usually <strong>decreased.</strong></p>\n<p>In <strong>ovarian dysfunction</strong> (option B) the negative feedback of ovarian hormones (estrogen) on pitutary and hypothalamus is lost. Hence, the levels of<strong> FSH is increased</strong> (&ge; 25 IU).</p>\n<p><strong>Asherman syndrome</strong> is characterised by a<strong> spectrum of intra uterine scarring</strong> including thin adhesions, dense bands, or complete obliteration of the uterine cavity. It occurs due to <strong>endometrial damage</strong> following <strong>vigorous curettage</strong>, usually in miscarriage, or elective abortion. Damage may also occur from other <strong>uterine surgeries</strong>&nbsp;such as myomectomy or cesarean delivery or from an infection related to an intrauterine device.</p>\n<div class=\"page\" title=\"Page 402\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Depending on the degree of scarring, patients may present&nbsp; with amenorrhea, hypomenorrhea or recurrent pregnancy loss due to inadequate placentation.</p>\n</div>\n</div>\n</div>\n<p>Asherman syndrome shows <strong>multiple filling defects</strong> on hysterosalpingography (HSG) or saline-infusion sonography. Definitive diagnosis requires <strong>hysteroscopy.&nbsp;Hysteroscopic lysis</strong>&nbsp;of adhesions is the preferred <strong>surgical treatment&nbsp;</strong>for the syndrome.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7106",
      "difficulty": "hard"
    },
    {
      "text": "Which among the following is an ideal treatment for a 55-year-old female with simple hyperplasia of the endometrium with atypia?",
      "choices": [
        {
          "id": 1,
          "text": "Simple hysterectomy"
        },
        {
          "id": 2,
          "text": "Medroxy progesterone acetate"
        },
        {
          "id": 3,
          "text": "Levonorgesterol"
        },
        {
          "id": 4,
          "text": "Radiotherapy"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Simple hysterectomy</strong> is the best treatment in a case of <strong>atypical</strong> endometrial <strong>hyperplasia&nbsp;</strong>in a <strong>peri-menopausal</strong> and<strong> post-menopausal</strong> female.</p>\n<p>Endometrial hyperplasia <strong>with atypia</strong> carries <strong>29% risk</strong> of <strong>developing into</strong> endometrial <strong>carcinoma</strong> and hence, must be <strong>treated</strong> with <strong>total abdominal hysterectomy</strong> (simple hysterectomy ). The&nbsp;presence of any <strong>concomitant endometrial cancer&nbsp;</strong>must be ruled out by doing <strong>fractional curettage</strong>&nbsp;(or dilatation and curettage) <strong>before</strong> doing a <strong>hysterectomy</strong>.</p>\n<p>If a premenopausal woman does not desire to undergo hysterectomy, <strong>progesterone</strong> can be given and the patient is followed up every 3-6 months. If the <strong>atypia</strong> <strong>persists</strong> during the follow-up<strong> hysterectomy</strong> should be performed.</p>\n<p>The table below summarizes the management of patients with endometrial hyperplasia</p><table>\n<tbody>\n<tr>\n<td><strong>Management of Endometrial hyperplasia</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td><strong>Hyperplasia without atypia</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pre-menopausal women</td>\n<td>Progesterone therapy</td>\n</tr>\n<tr>\n<td>Postmenopausal women:\n<ul>\n<li>Simple hyperplasia without atypia</li>\n<li>Complex hyperplasia without atypia</li>\n</ul>\n</td>\n<td>\n<p>&nbsp;</p>\n<ul>\n<li>Follow up without therapy</li>\n<li>Progesterone therapy</li>\n</ul>\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td><strong>Hyperplasia with atypia</strong></td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>Pre-menopausal women</td>\n<td>\n<p>If patient wishes to preserve uterus,give High-dose progesterone therapy</p>\n<p>If atypia persists, then perform Total abdominal hysterectomy</p>\n</td>\n</tr>\n<tr>\n<td>Peri-menopausal women</td>\n<td>Total abdominal hysterectomy</td>\n</tr>\n<tr>\n<td>Post-menopausal women</td>\n<td>Total abdominal hysterectomy +BSO (bilateral salphingo-ophorectomy)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0267",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following is an irreversible method of contraception?",
      "choices": [
        {
          "id": 1,
          "text": "Laparoscopic tubal ligation"
        },
        {
          "id": 2,
          "text": "Copper-T"
        },
        {
          "id": 3,
          "text": "Implanon"
        },
        {
          "id": 4,
          "text": "LNG-IUD"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Among the given options,<strong> Laparoscopic tubal ligation</strong> is an <strong>irreversible</strong> method of contraception.</p>\n<p><strong>Tubal sterilization</strong> can be achieved by three methods which are:</p>\n<ul>\n<li><strong>Electrocoagulation</strong> is used for the destruction of a segment of the tube</li>\n<li><strong>Mechanical occlusion</strong> of the tube using a <strong>silicone rubber band</strong> (Falope ring) or a <strong>spring-loaded clip</strong> (Hulka Clemens clip)</li>\n<li><strong>Suture ligation</strong> with or without tubal segment excision such as <strong>Pomeroy's </strong>method, <strong>Uchida's </strong>method, <strong>Irving's</strong> method, etc.</li>\n</ul>\n<p>Intrauterine devices such as <strong>copper T</strong> and <strong>LNG-IUDs</strong>&nbsp;and <strong>implants</strong> belong to the category of <strong>long acting reversible contraception</strong>.</p>\n<p>In <strong>copper-T</strong> (Option B) a copper wire is wrapped around a polypropelene vertical frame. The copper in the device causes an intense local <strong>inflammatory response</strong> in the uterus that leads to lysosomal activation and activation of other inflammatory processes that are <strong>spermicidal</strong>. The <strong>Cu-T 380A</strong> is approved for <strong>10 years</strong> of continuous use.</p>\n<div class=\"page\" title=\"Page 141\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>LNG-IUD</strong> (Option D) is a T-shaped polyethylene structure enclosed by a cylinder containing <strong>levonorgesterl</strong>. This hormone is <strong>released continuously</strong> through the permeable cylinder. The <strong>progestin</strong> makes the <strong>endometrium atrophic</strong> and stimulates the production of<strong> thick cervical mucus</strong> that blocks sperm penetration into the uterus. It also <strong>decreases tubal motility</strong>, thereby preventing fertilization.</p>\n<p><strong>Nexplanon</strong> has now replaced <strong>implanon</strong> (Option C) which was a previously used etonogestrel implant. <strong>Nexplanon</strong> is a&nbsp;single-rod&nbsp;<strong>progestin&nbsp;etonogestrel&nbsp;</strong>(68 mg) containing <strong>subdermal implant</strong> that provides contraception over <strong>3</strong> <strong>years</strong>. Its mechanism of action is by suppression of ovulation, thickened cervical mucus, and endometrial atrophy. <strong>Irregular bleeding</strong> is an important <strong>side effect</strong> of the implant. This method of contraception is reversible in nature.</p>\n</div>\n</div>\n</div>\n<p>Image below shows implanon:&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/93b84bc55f1f4a80934bc0d3c0472316x1280x699.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7cad8d8be930468999f506b29ccd9db5x1280x5453.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Methods of contraceptions</h3><table>\n<tbody>\n<tr>\n<td><strong>Methods</strong></td>\n<td><strong>Advantages</strong></td>\n<td><strong>Disadvantages</strong></td>\n</tr>\n<tr>\n<td><strong>Barrier</strong></td>\n<td>\n<ul>\n<li>Prevents STD, HIV</li>\n<li>The incidence of Ca cervix reduced</li>\n<li>Effective if used properly</li>\n<li>No contraindication use</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Cumbersome</li>\n<li>&nbsp;Coital dependent</li>\n<li>&nbsp;Short term</li>\n<li>&nbsp;High failure rate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Lactation</strong></td>\n<td>\n<ul>\n<li>Beneficial to the newborn</li>\n<li>Contraceptive action (non-ovulatlon) 6 months</li>\n</ul>\n</td>\n<td>Short-term benefit</td>\n</tr>\n<tr>\n<td><strong>IUCD</strong></td>\n<td>\n<ul>\n<li>Long-term use</li>\n<li>Effective</li>\n<li>Coital Independent</li>\n</ul>\n</td>\n<td>Side effects<br />&bull; Failure rate 1-3%<br />&bull; Contraindicated In few</td>\n</tr>\n<tr>\n<td><strong>Hormones</strong></td>\n<td>Effective 99-100% long-term use of beneficial effects<br />of OC coital independent</td>\n<td>Side effects<br />&bull; Not used during lactation<br />&bull; Contraindicated In few<br />&bull; Requires Surgery for implantation</td>\n</tr>\n<tr>\n<td><strong>Surgery</strong></td>\n<td>Permanent and effective</td>\n<td>Surgical complications surgery required.<br />&bull; Not suited in low parity women</td>\n</tr>\n<tr>\n<td><strong>Postcoital</strong></td>\n<td>Effective 95-98% short-term use</td>\n<td>Failure in 1-5%<br />Not used as contraceptives</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7105",
      "difficulty": "easy"
    },
    {
      "text": "What is the most useful test in vesicovaginal fistula?",
      "choices": [
        {
          "id": 1,
          "text": "Cystoscopy"
        },
        {
          "id": 2,
          "text": "3 swab test"
        },
        {
          "id": 3,
          "text": "MRI"
        },
        {
          "id": 4,
          "text": "Cystometry"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Cystoscopy</strong> is the <strong>most useful test</strong> and also the <strong>investigation of choice</strong> for<strong> vesicovaginal fistula</strong> (VVF).</p>\n<p>Cystoscopy or<strong> cystourethroscopy</strong> helps to visualize the <strong>size</strong> of the fistulas, the exact <strong>location</strong> of <strong>multiple fistulas </strong>and their <strong>proximity</strong> to the <strong>ureteral</strong> <strong>orifice</strong><strong>.</strong> It can also <strong>assess</strong> the <strong>bladder</strong> mucosa for any <strong>injuries. </strong></p>\n<p>The <strong>3-swab test</strong> (Option B) is done to identify the <strong>types of genitourinary fistula</strong>.</p>\n<p>In this test, <strong>three sterile</strong> pieces of cotton swabs are <strong>serially placed</strong> in the vaginal cavity, while 50-100ml of <strong>methylene blue solution</strong> is instilled in the <strong>bladder</strong> using a catheter. The cotton swabs are placed one at the <strong>vault,</strong> one at the <strong>middle</strong>, and one just <strong>above the introitus.</strong></p>\n<p>Interpretation:</p>\n<ul>\n<li><strong>Uppermost</strong> swab gets <strong>wet</strong> and <strong>not stained</strong> - the leak is from the ureter, as seen in <strong>u</strong><strong>reterovaginal</strong> fistula</li>\n<li><strong>Middle</strong> swab gets <strong>stained</strong> - the leak is from the bladder, as seen in <strong>v</strong><strong>esicovaginal</strong> fistula</li>\n<li><strong>Lowermost</strong> swab gets <strong>stained</strong>- the leak is from the urethra,as seen in <strong>u</strong><strong>rethrovaginal</strong> fistula</li>\n</ul>\n<p>The below image shows the 3-swab test.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/62d20aefbac94edeb295d66f846d17ccx1280x1082.JPEG\" alt=\"Explanation Image\"><p>Option C: <strong>MRI</strong> is usually not needed for the diagnosis of VVF. They can be used to study <strong>vesicouterine fistulas</strong>.</p>\n<p>Option D: <strong>Cystometry</strong> is done to measure the capacity of the bladder. It is used to investigate <strong>urge incontinence</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7103",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old woman has cervical intraepithelial neoplasia III. What would be the management?",
      "choices": [
        {
          "id": 1,
          "text": "Hysterectomy"
        },
        {
          "id": 2,
          "text": "Trachelectomy"
        },
        {
          "id": 3,
          "text": "Conization"
        },
        {
          "id": 4,
          "text": "Colposcopy with LEEP"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Colposcopy with LEEP</strong> would be appropriate management for <strong>CIN III</strong>.</p>\n<p><strong>Loop electrosurgical excision procedure (LEEP)&nbsp;</strong>is an <strong>opd procedure</strong> done under <strong>colposcopic view</strong> and local anesthesia.Here, a low voltage current is passed through the loop and a cone of tissue is removed from the cervix. This procedure causes <strong>minimal bleeding</strong> and the tissue removed is sent for histopathological examination (HPE). This is the <strong>treatment of choice</strong> for <strong>CIN 2&amp;3</strong> of <strong>any age and parity</strong>.</p><hr><h3>Related Pearl: Management of CIN</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1f5d51f1183f4d35857dd881e7f7f708x1280x1886.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7104",
      "difficulty": "medium"
    },
    {
      "text": "A pregnant woman has gestational diabetes mellitus (GDM) and her blood glucose levels are well controlled on insulin. What will be the appropriate gestational age for her delivery?",
      "choices": [
        {
          "id": 1,
          "text": "37 weeks"
        },
        {
          "id": 2,
          "text": "39 weeks"
        },
        {
          "id": 3,
          "text": "38 weeks"
        },
        {
          "id": 4,
          "text": "40 weeks"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>most appropriate time</strong> for the delivery in this patient would be <strong>39 weeks</strong> as she has good glycemic control with insulin.</p>\n<p>The<strong> timing for delivery</strong> in a pregnant woman with GDM would vary <strong>depending </strong>on the<strong> control </strong>of <strong>glucose</strong> levels &amp; mode of treatment.</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\"><strong>Appropriate timing for delivery in gestational diabetes</strong></td>\n</tr>\n<tr>\n<td><strong>Well-controlled</strong> with diet</td>\n<td>39 weeks to 40 weeks +6 days</td>\n</tr>\n<tr>\n<td><strong>Well-controlled</strong> with <strong>insulin/oral agent</strong></td>\n<td>39 weeks to 39 weeks + 6 days</td>\n</tr>\n<tr>\n<td><strong>Co-morbidity</strong> or suboptimal control</td>\n<td>Induction before 39 weeks</td>\n</tr>\n<tr>\n<td>With <strong>poor glycemic control</strong></td>\n<td>\n<ul>\n<li>Reasonable to deliver at 37 to 38 weeks + 6 days of gestation &nbsp;</li>\n<li>In extreme cases where all efforts for glycemic control have failed induction prior to 37 weeks (no clear cut guideline )</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7101",
      "difficulty": "medium"
    },
    {
      "text": "A female presents with 35 weeks and 3 days of gestation, AFI = 5 and there is no end-diastolic blood flow. What is the management?",
      "choices": [
        {
          "id": 1,
          "text": "Immediate termination"
        },
        {
          "id": 2,
          "text": "Give surfactant and wait till 36 weeks"
        },
        {
          "id": 3,
          "text": "Do Doppler everyday to check for reversion"
        },
        {
          "id": 4,
          "text": "Terminate after 37 weeks"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given case scenario is suggestive of <strong>fetal compromise</strong>. The management in this patient is<strong> immediate termination&nbsp;</strong>of pregnancy.&nbsp;Since this pregnancy has crossed 34 weeks, it can be&nbsp;terminated by cesarean section.</p>\n<p><strong>Abnormal flow patterns in the umbilical artery:</strong></p>\n<ul>\n<li>Reduced end-diastolic flow indicates uteroplacental insufficiency (S/D ratio increases)</li>\n<li>Absent end-diastolic flow suggests fetal compromise, hence the pregnancy is terminated by C-section if &gt;34 weeks.</li>\n<li>Reverse end-diastolic flow suggests impending doom of death, hence the pregnancy is terminated by C-section if &gt;32 weeks.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/654e3bf623cd424fa7a39244e1b639a6x1280x2763.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7068",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following heart sounds would be normal in pregnancy?",
      "choices": [
        {
          "id": 1,
          "text": "S3"
        },
        {
          "id": 2,
          "text": "S4"
        },
        {
          "id": 3,
          "text": "Fixed splitting of S2"
        },
        {
          "id": 4,
          "text": "Pericardial knock"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Among the given options, the presence of <strong>third heart sound</strong> (<strong>S3</strong>) is <strong>normal</strong> in pregnancy.</p>\n<p>The <strong>third heart sound</strong> (S3) occurs due to <strong>rapid diastolic filling</strong>&nbsp;that is seen secondary to the <strong>physiological hypervolemia</strong> that occurs during the pregnancy.</p>\n<p>Other <strong>normal auscultatory</strong> findings include:</p>\n<ul>\n<li><strong>First</strong> heart sound is<strong> loud</strong> with an <strong>exaggerated split</strong></li>\n<li><strong>Second</strong> heart is <strong>loud</strong> but normal</li>\n<li><strong>Third</strong> heart sound is <strong>loud</strong> and <strong>easily heard</strong></li>\n<li><strong>Systolic murmur</strong> of grade<strong>&lt;3/6</strong></li>\n<li><strong>Mammary murumur</strong> or continous machinery murmur</li>\n<li>Apex beat shifted to<strong> 4th intercostal space</strong></li>\n</ul><hr><h3>Related Pearl: Cardiovascular changes in pregnancy</h3><ul>\n<li class=\"p1\">The resting pulse rate increases by <strong>10 beats</strong>/<strong>min</strong></li>\n<li class=\"p1\">The apex is moved laterally&nbsp;</li>\n<li class=\"p1\">Cardiac output remains elevated throughout (maximum in the immediate postpartum period)</li>\n<li class=\"p1\">X-Ray shows a larger cardiac silhouette (due to benign pericardial effusion and shifted apex)</li>\n<li class=\"p1\">ECG: Slight&nbsp;<strong>left axis </strong>deviation</li>\n</ul>\n<p><strong>Heart sounds:</strong></p>\n<ul>\n<li class=\"p1\">First heart sound: Loud with an exaggerated split</li>\n<li class=\"p1\">Second heart sound: Normal but loud</li>\n<li class=\"p1\">Third heart sound: Loud and easily heard</li>\n</ul>\n<p><strong>Murmurs:</strong></p>\n<ul>\n<li>A systolic murmur<strong>&nbsp;</strong>that was intensified during inspiration or expiration</li>\n<li class=\"p1\">A soft diastolic murmur (in 20%)</li>\n<li class=\"p1\">Continuous murmur&nbsp;arising from the breast vasculature (in 10%)</li>\n</ul><hr><h3>Related Pearl: Hematological changes in pregnancy</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Increases</strong></p>\n</td>\n<td>\n<p><strong>Decreases</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hemoglobin <strong>mass</strong></p>\n</td>\n<td>\n<p>Hemoglobin <strong>concentration</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total plasma protein</strong></p>\n</td>\n<td>\n<p><strong>S.urea/creatinine/uric acid</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Globulin</strong></p>\n</td>\n<td>\n<p>Albumin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neutrophils</p>\n</td>\n<td>\n<p>Platelets</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Fibrinogen</strong></p>\n</td>\n<td>\n<p><strong>Blood urea nitrogen</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Factors 7,8,9,10</strong></p>\n</td>\n<td>\n<p>Factor 11,13</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Insulin</strong></p>\n</td>\n<td>\n<p>S.Na/K/Ca/Mg/I<sub>2</sub></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>LDL,HDL,apolipoprotiens</p>\n</td>\n<td>\n<p>-</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>S.Transferrin</strong> and TIBC(Total</p>\n<p>Iron binding capcity)</p>\n</td>\n<td>\n<p>S.Iron, ferritin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>CRP(C-Reactive protein)</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Placental phosphatase</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p><strong>Total alkaline phosphatase</strong></p>\n</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<p>ESR 4x rise</p>\n</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7079",
      "difficulty": "easy"
    },
    {
      "text": "A pregnant woman with cardiac disease is on warfarin therapy. When will the final switch to heparin be advised?",
      "choices": [
        {
          "id": 1,
          "text": "At the onset of labour"
        },
        {
          "id": 2,
          "text": "34 weeks"
        },
        {
          "id": 3,
          "text": "36 weeks"
        },
        {
          "id": 4,
          "text": "40 weeks"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The final <strong>switch to heparin</strong> in a pregnant women is advised at <strong>36 weeks of pregnancy</strong>&nbsp;and is continued till 7 days postpartum.</p>\n<p>This switch is made from warfarin to heparin at 36 weeks, as <strong>warfarin</strong> is a<strong> strong anticoagulant</strong> which can cause <strong>post</strong> <strong>partum hemorrhage</strong> in the mother at the time of labour and can also cross the placenta into the fetal blood and can increase the risk of <strong>intracranial hemorrhage</strong> in the <strong>fetus</strong></p>\n<p>The below given algorithm is followed for administration of anticoagulants in a pregnant female:</p><table>\n<tbody>\n<tr>\n<td>Period of pregnancy</td>\n<td>Anticoagulation of choice</td>\n</tr>\n<tr>\n<td>First trimester</td>\n<td>\n<p>If dose of warfarin <strong>&lt; 5mg/day</strong>&ndash; <strong>continue warfarin till 36 weeks&nbsp;</strong></p>\n<p>If dose of <strong>warfarin &gt; 5mg</strong> /day or warfarin embryopathy present &ndash;<strong> replace it with heparin / LMWH</strong></p>\n</td>\n</tr>\n<tr>\n<td>From <strong>12 weeks to 36 weeks</strong></td>\n<td><strong>warfarin</strong></td>\n</tr>\n<tr>\n<td><strong>At 36 weeks</strong></td>\n<td>Switch to <strong>LMWH</strong></td>\n</tr>\n<tr>\n<td>1 week before EDD / 3 days before EDD</td>\n<td>Switch to <strong>UFH</strong> (as LMWH have longer T1/2&ndash; increased chances of PPH)</td>\n</tr>\n<tr>\n<td>On the day of delivery</td>\n<td>Stop all anticoagulant</td>\n</tr>\n<tr>\n<td>6 hrs after vaginal delivery / 6-12 hrs after cesarean&nbsp;&nbsp;</td>\n<td>Restart UFH and Warfarin. When INR is 2.5 to 3 withdraw UFH &amp; continue warfarin</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>LMWH- low molecular weight heparin<br />UFH- Unfractionated heparin</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7045",
      "difficulty": "easy"
    }
  ]
}